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Abstract 
 
One of the promising strategies concerning molecular therapy is gene 
therapy. By delivering genes for therapeutic purposes, we may treat both acquired and 
inherited genetic diseases. Non-viral vectors appear as a safer method of gene delivery 
into the cell, although not as efficient as viral vectors. Cationic lipids are an example of 
non-viral methods that have been thoroughly researched in the past few years as an 
effective tool to promote effective transfection of genetic material. 
This project was focused on the development and characterization of 
lipoplexes based on dioctadecyldimethylammonium bromide/ chloride (DODAB/C): 1-
monooleoyl-rac-glycerol (MO) liposomes with the inclusion of a cholesterol derivative 
3β [N-(N’,N’- dimethylaminoethane)carbamoyl cholesterol (DC-Chol) for transfection. 
Monoolein (MO) is a neutral lipid that seems to function well as a helper lipid since it 
affects the physicochemical properties of the lipoplexes and interferes with lipoplex-
cell interactions. The physicochemical characteristics of DODAB/MO cationic liposomes 
were previously studied and their transfection capacity evaluated (Neves Silva et al, 
2012). The results show a successful mediation of in vitro cell transfection by the 
DODAB:MO formulations. DC-Chol is a synthetic cationic molecule derivate from 
cholesterol. It has been used before in lipoplex assemblies in order to enhance 
transfection efficiency.  
The results in this project show that the counterion exchange (bromide and 
chloride) has a significant effect in terms of particle size and Zeta potential. 
Furthermore, the liposome preparation method affects the physico-chemical 
properties of the particles, as well as the citotoxixity and transfection efficiency. The 
inclusion of DC-Chol has different effects on transfection efficiency and citotoxicity 
when included in DODAB:MO or DODAC:MO lipoplexes, depending on the molar ratio 
and on the preparation method of the liposomes.  
Overall, DODAC:MO:DC-Chol lipoplexes  arise as promising non-viral vectors 
for transfection. 
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Resumo 
 
A terapia génica é uma das estratégias promissoras no que diz respeito à terapia 
molecular. Ao entregar às células e tecidos genes para fins terapêuticos, tanto doenças 
genéticas herdadas como adquiridas podem ser tratadas. Os vectores não virais 
aparecem como um método mais seguro de entrega de genes no interior das células, 
apesar de não serem tão eficazes como os vectores virais. Os lípidos catiónicos são um 
exemplo de métodos não virais que têm sido exaustivamente investigados nos últimos 
anos como meio capaz de realizar uma transfeção eficaz do material genético. 
Neste projecto, focou-se no desenvolvimento e caracterização de lipoplexos 
baseados em lipossomas catiónicos de Brometo/Cloreto de Dioctadecildimetilamónio 
(DODAB/C): Monooleína (MO) e com a inclusão um derivado de colesterol (DC-Chol), a 
fim de testar a sua eficácia de transfecão. A monooleína (MO) é um lípido neutro que 
parece funcionar bem como lípido auxiliar, uma vez que afeta as propriedades físico-
químicas dos lipoplexos e interfere com as interações lipoplexo-célula. As 
características físico-químicas dos lipossomas catiónicos DODAB:MO foram 
previamente estudadas e a capacidade de promover transfecção de lipoplexos 
preparados a partir destes lipossomas foi demonstrada (Neves Silva et al., 2012). Os 
resultados deste estudo revelaram sucesso na transfeção in vitro de células mediada 
pelas formulações testadas de DODAB:MO. O DC-Chol é uma molécula catiónica 
sintética derivada do colesterol. Esta molécula é muitas vezes utilizada em 
composições liposómicas utilizadas para produzir lipoplexos a fim de aumentar a 
eficiência de transfeção dos mesmos. 
Os resultados mostram que a troca de contra ião (brometo e cloreto) tem um 
efeito significativo em termos de tamanho médio e do potêncial ζ das partículas. Além 
disso, o método de preparação dos lipossomas também afecta as propriedades físico-
químicas das partículas, bem como a sua eficiência de transfeção e citotoxicidade. A 
inclusão de DC-Chol tem efeitos diferentes sobre a citotoxicidade e a eficiência de 
transfeção quando incluídos em lipoplexos DODAB:MO e DODAC:MO, dependendo da 
fração molar incluída e do método de preparação dos lipossomas. 
Em geral, os lipoplexos DODAC:MO:DC-Chol surgem como promissores vetores 
não virais para transfeção in vitro. 
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I. Introduction 
 
1. Gene therapy 
The concept of gene therapy has evolved in the last few years. At first, this new 
technology seemed a revolutionary promise to cure almost any disease to which the 
genetic or molecular basis was understood. Primarily, gene therapy’s main goal was 
replacing a deficient gene in a genetically inherited disease with a normal copy of that 
gene. This goal was soon extended to acquired diseases. A more actual approach offers 
a wider perspective by referring to the potential use of nucleic acids such as siRNAs, 
plasmid DNA or antisense oligonucleotides in order to modulate gene function for 
therapeutic purposes (Hoag, 2005; Wasungu, 2006). 
 
1.1 Viral and non viral methods 
Concerning the vectors used for nucleic acid transfer, we can roughly divide 
vectors into two categories: viral and non-viral methods.  
Viral methods are based on the construction of viral particles containing the 
gene of interest within the viral genome. The viral vectors used include Retrovirus, 
Adenovirus and Lentivirus. These viral particles lack pathogenic functions and are 
incapable of self-replication. However, recombination events may occur and generate 
an infection-competent virus (Wasungu, 2006). Additional hazards include innate 
mutational issues, particularly with adenovirus, mutational insertion risks, mostly 
derived from retrovirus and potential appearance of oncogenicity (Thomas et al., 
2003). These hazards have seriously limited the clinical usefulness of this gene-delivery 
method (Glover et al., 2005). Clinical trials like the one reported by Raper and 
colleagues (Raper et al., 2003) where a patient with partial ornithine transcarbmaylase 
(OTC) deficiency submitted to adenoviral gene transfer died of systemic inflammatory 
reaction confirm the safety issues inherent to viral methods. 
Non-viral methods involve the delivery of DNA containing the gene of interest 
by means of physical or chemical techniques. These delivery systems rise as a safer 
alternative to viral methods as they are immunologically inert, easier to produce, and 
can accommodate larger molecules and wider variety of cargo then the viral systems, 
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although the efficiency of transfection is lower (Glover et al., 2005). There is a variety 
of nonviral delivery systems that have been developed for gene therapy in different 
clinical settings. As examples of conventional non-viral methods for gene delivery, we 
have the physical methods like DNA microinjection into cells, electroporation and 
ballistic delivery, which promote the entry of nucleic acid into the cells by disrupting 
the plasma membrane with electric pulses and bombardment of DNA-coated metal 
particles at high velocity respectively (Glover et al., 2005). There are also cationic 
polymer based methods, like cationic polymer-based gene delivery systems 
(polyplexes) and DNA/Cationic Liposomes complexes (lipoplexes) (Glover et al., 2005; 
Li and Huang, 2000; Niidome and Huang, 2002; Templeton, 2001). This study will focus 
on lipoplexes as a nonviral gene delivery system.  
 
1.2 DNA (deoxyribonucleic acid) 
The DNA molecule carries the genetic information on which human and other 
life forms are built. Therefore, it makes all sense that the DNA molecule is used in the 
development of a group of therapeutics modeled on its endogenous structure. 
Briefly, DNA has a three-dimensional structure consisting in a double helix 
formed by two helical strands which are coiled around a common axis (Figure 1A). 
Each strand is composed by nucleotides (also called bases), monomers which consist of 
a purine or pyrimidine base, a sugar (Deoxyribose in the case of DNA) (Figure 1B) and a 
phosphate group. DNA is composed by four different bases: thymine (T), guanine (G), 
adenine (A) and cytosine (C) (Figure 1C) The bases on one strand unite to the bases of 
the opposite strand internally via hydrogen bonds between the purine and pyrimidine 
bases, linking the two strands together (Figure 1A)(Lodish et al., 1996). 
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A  
B  C  
 
Figure 1. (A) DNA structure; (B) Deoxyribose present in DNA; (C) nucleotides that compose 
DNA (Lodish et al., 1996). 
 
 
1.2.1 Plasmid DNA 
Plasmids are high molecular weight, circular, double stranded DNA molecules 
which are distinct from chromosomal DNA. They occur naturally in bacteria and in 
some lower eukaryotic cells, like yeasts, and are duplicated before every cell division, 
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the same as the host’s chromosomal DNA. Different types of plasmids can be 
constructed in vitro and often used as vectors for DNA cloning (Stryer, 1996). 
 In a typical plasmid we can find a genome with promoter regions which are 
critical for the transcription process, a multiple cloning site where DNA fragments may 
be inserted to the plasmid and at least a gene expressing antibiotic resistance (Figure 
2). 
 
 
 
Figure 2. Map of the plasmid DNA used in this thesis (pSV-β-Galactosidase Vector). 
 
 
Plasmids can easily be isolated and purified after being grown in bacteria. This 
may be done by transferring the plasmid into bacteria and allowing the bacteria to 
grow overnight, followed by bacteria lysis. 
The application of plasmid DNA in gene therapy involves the introduction of a 
transgene into the cells in order to correct genetic errors inherent to the production of 
incompetent copies of a given protein or even to the lack of protein production 
altogether. The efficiency of this treatment depends on the access gained by the 
plasmid DNA to the nucleus through the nuclear pores, once it entries the cytoplasm. 
Besides disease treatment, plasmids may be applied to function as DNA vaccines or 
even in suicide gene therapy. So, on a molecular level, the plasmid DNA molecules may 
be considered as pro-drugs (Patil et al., 2005; Uherek and Wells, 2000). 
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2. Gene delivery 
Some conditions are vital for a successful gene delivery. These conditions are the 
condensation of the DNA and its protection against intracellular nucleases, lipoplex 
adhesion onto the cell surface, lipoplex internalization followed by fusion with the 
endosome membrane, DNA escape from the endosome and, finally, DNA entry into 
the nucleus and its expression (Hui et al., 1996; Zhdanov et al., 2002).  
 
2.1 Transfection mediated by lipoplexes 
 
2.1.1 Cellular binding 
Lipoplexes usually bind to the cellular surface mainly as a result of nonspecific 
ionic interactions between negative charges on the membrane surface and positive 
charges of the lipoplexes. There may also be specific targeting ligands interactions 
when these are incorporated in the system (Khalil et al., 2006). The presence of serum 
proteins, present in the culture medium, can interfere with the interaction between 
cells and lipoplexes, decreasing the efficiency of the transfection. It seems that the 
extent of interference of the serum components with the transfection efficiency is 
related to the cationic lipid chemical structure as well as the liposomal formulation and 
charge ratio (+/-) of the lipoplexes (Zelphati et al., 1998). Nevertheless there is still 
incomplete knowledge on the lipoplex-serum interaction. 
 
2.1.2 Endocytosis 
Given the general cellular membrane structure, the presence of a specific ligand 
as well as the vectors overall charge content will influence the way lipoplexes interact 
with the membrane (Chestnoy and Huang, 2000). There are two main pathways by 
which DNA-Lipid complex may enter the cell. One way is by endocytosis followed by 
the destruction of an endosome inside the cell and the other way is by direct fusion of 
the lipoplex with the cellular membrane (Figure 3). Endocytosis is the major way by 
which most complexes enter the cell and only a small percentage is internalized by 
direct fusion with the cell membrane (Hoekstra et al., 2007; Khalil et al., 2006). It 
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seems that lipoplexes may enter through clathrin-mediated endocytosis or caveolae-
mediated endocytosis (Hoekstra et al., 2007). For example, Rejman (Rejman et 
al.,2005) studied the effect of inhibitors of clathrin-mediated endocytosis 
(chloropromazine and K+ depletion) and of caveolae-mediated endocytosis (filipin and 
genistein) on A549 pneumocytes and HeLa cells of FITC–poly-L-lysine-labeled 
DOTAP/DNA lipoplexes and on their transfection efficiency with the luciferase gene, 
concluding that the lipoplex uptake occurs only by clathrin-mediated endocytocis and 
transfection efficiency was entirely abolished by blocking clathrin-mediated 
endocytocis, whereas no effect was observed with the inhibition of the caveolae 
pathway. It seems important in these kinds of studies to establish a direct correlation 
between the pathway of entry and the transfection efficiency so that one can deduce 
how the pathway of entry may relatively contribute to a good transfection activity.  
 
 
 
Figure 3. Proposed mechanisms of lipoplex entry into the cell (Zhdanov et al., 2002). 
 
 
Once inside the endosome, it is important that plasmid DNA escapes to the 
cytosol before reaching the lysosomes to avoid DNA degradation (Hoekstra et al., 
2007).  
The size of the lipoplexes is an important aspect to consider in determining the 
nature of the entry pathway by endocytosis. The nature of the entry pathway and its 
efficiency can also be cell type dependent, according to the endocytic machinery of the 
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cell. For instance, Rejman (Rejman et al., 2004) studied the effect of cholesterol 
depletion and inhibitors on the internalization of fluorescent latex beads of defined 
various sizes, ranging from 50nm to 1000nm, by non-phagocytic B16 cells. The study 
revealed that the size of the particles strongly influenced the mechanism by which 
they were internalized as well as their subsequent intracellular route. Internalization of 
particles with sizes up to 200nm involved clathrin-coated pits. For particles with 
500nm, the caveolae-mediated internalization becomes the predominant pathway of 
entry.  
Still, the relative contribution of either pathway in lipoplex internalization and 
their relative contribution to the transfection efficiency of lipoplexes need a better 
insight (Zuhorn et al., 2007). 
 
2.1.3 Endosomal escape 
Escape from the (early) endosome into the cytosol is a critical step in order to 
avoid plasmid DNA degradation in the lysosome. Thus, it also constitutes one of the 
main criteria to successful transfection efficiency (Hoekstra et al., 2007). The escape 
into the cytosol by adenovirus involves the lysis of the endosomal membrane 
structure, and the hexagonal structure of the lipoplexes is thought to play a parallel 
role with the adenovirus mechanism to transfect cells (Wasungu and Hoekstra, 2006), 
although naturally, the lipolexes lack the protein machinery to promote the endosomal 
membrane destabilization.  
A mechanism of endosomal membrane destabilization involving lipoplex-induced 
processes seems to be promoted by non-lamellar phases, including the hexagonal HII 
and HI or a cubic phase. Apparently, lipoplexes that adopt these structures strongly 
promote transfection, and this fact is consistent with this mechanism.  The inclusion of 
PEGylated lipid derivatives, for example, in the DNA/Cationic lipid complexes, appears 
to have a stabilizing effect on the membrane bilayer structure and, at the same time, 
an inhibition effect on DNA dissociation. Moreover, the phospholipid 
phosphatidylserine (PS), present in the outer leaflet of the endosomal membrane 
seems to play an important role in this process as it facilitates the lamellar to non-
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lamellar hexagonal-phase transition of the lipoplexes and thus, releasing the DNA from 
the lipoplex (Hoekstra et al., 2007; Wasungu and Hoekstra, 2006). 
Then again, there may be a translocation of the cationic lipids into the 
endossomal membrane by the interaction of non-lamellar intermediates followed by a 
local increase which may give rise to pore formation of transient stability and 
membrane destabilization. The rate of lateral diffusion of the surrounding membrane 
lipids determines this. And so, the DNA may gain access to the cytosol (Hoekstra et al., 
2007).  It is still unclear if DNA dissociation occurs before or simultaneously with the 
perturbation of the endosomal membrane. Furthermore, it is also unclear if the 
complete lysis of the endosome is necessary for the DNA transfer or if it may occur 
across the perturbed membrane (Hoekstra et al., 2007). 
New insights on molecular mechanisms underlying lipoplex induced endosomal 
membrane destabilization can be given by modeled endosomal membranes for 
instance. Berezhna and coleagues (Berezhna et al., 2005) performed a study using 
GUVs as model endosomal membranes in order to investigate what part some 
individual phospholipids play in interaction with lipoplexes, using laser scanning 
imaging in conjunction with fluorescence cross-correlation analysis.  
Although there has been considerable progress in recent years in the study and 
knowledge of the barriers in lipoplex mediated transfection, there’s still a long way to 
go. Further studies are needed to understand the relative contribution of endocytosis 
in terms of effectiveness of internalization, efficiency of gene escape and, eventually, 
transfection efficiency, since this is the major pathway of entry of lipoplexes. 
 
2.1.4 Nuclear Delivery 
 
The final barrier to lipofection, and probably the most challenging too, is the 
nuclear membrane. Indeed, when plasmid DNA encoding β-galactosidase is injected 
directly into the nucleus, the gene expression was much higher when compared with 
when the same plasmid was injected into the cytosol. Furthermore, when DNA 
complexed with cationic lipids is directly injected into the nucleus, the complexed DNA 
is not expressed, suggesting that DNA has to be released from the lipoplex somewhere 
in the cytoplasm (Pollard et al., 1998). 
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During mitosis, the nuclear membrane is fragmented and this would allow the 
plasmid DNA into the nucleus. This seems to be the most widely accepted explanation 
as to how the DNA is delivered to the nucleus, so cell division plays an important role 
in the nuclear translocation of transgenes.This fact, nevertheless, cannot be the only 
explanation, since nondividing cells are targeted in in vivo transfection (Khalil et al., 
2006). 
 
3. Lipids 
 
Lipids can have various usages in biological systems which make them important 
molecules for living beings. Some lipids assemble themselves into bilayer lipid 
membranes that separate cellular compartments from the external environment and 
participate in cellular regulation by mediating signal transduction processes. The lipid 
molecules found in the membrane are amphipathic molecules, which signifies they 
have a hydrophilic tail oriented to the inner part of the bilayer and a hydrophobic head 
oriented to the aqueous environment.  
The model proposed by Singer and Nicholson (1972), called the “fluid mosaic” 
(Figure 4) proposes that biological membranes are composed of lipids, proteins and 
carbohydrates and describe that the nature of the lipid bilayer allows for considerable 
molecular motion in the lipid matrix and provides an appropriate milieu for the 
function of the proteins found in the membrane. (Alberts et al., 1994)  
 
Figure 4. Cellular membrane according to the “fluid mosaic” model and phospholipid mobility 
within the bilayer (adapted from Singer and Nicolson, 1972). 
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Depending on the structure and function, lipids can be classified into different 
groups. Among the lipids that constitute biological membranes we can find three 
groups: glycerophospholipids, sphingolipids, and sterols. (Chang, 2005)  
The surrounding environment is a very important factor in the structural 
behavior of lipids.  Lipids may adopt different conformations when hydrated and the 
propensity of these molecules to adopt different phases as a response to some 
external variables like pH, presence of ions or temperature is referred to as lipid 
polymorphism. These phases include the micellar, the lamellar, the cubic and the 
inverted hexagonal phases (Figure 5).  
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Figure 5. Impact of packing parameter p on lipid assemblies formed in aqueous solutions 
(Balazs and Godbey, 2011). 
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The packing parameter allows to predict which structure the molecules will 
adopt (Balazs and Godbey, 2011). This packing parameter is given by: 
 
  
 
  
 
 
And is defined as the ratio of the hydrocarbon volume, v, and the product of the 
effective head group area,   , and the critical length of the lipid tail, l . It is also related 
to the curvature by: 
 
  
      
   
 
 
 
Where H is the mean curvature and K is the Gaussian curvature (Antonielli and 
Förste, 2003). 
When p < 1/3 the molecules adopt preferentially a conical shape, forming 
conventional spherical micelles. When 1/3 < p < 1/2, the molecules adopt a geometry 
resembling a truncated cone, forming non-spherical micelles. The lipidic bilayer is 
formed when 1/2 < p < 1, and the molecules adopt a nearly cylindrical shape. At last, 
when p > 1, we can see the formation inverted structures with negative spontaneous 
curvature (Antonielli and Förster, 2003; Balazs and Godbey, 2011; Ryhänen, 2006).  
Lipids can also exist in “gel” state (Lβ) or in a fluid “liquid crystalline” state (Lα) 
depending on the temperature (Figure 6). The transition temperature (Tm) is specific 
for each lipid. The lipids arranging in a gel state, bellow the transition temperature, are 
rigid and in order. This is due to the carbon-carbon bonds of the acyl chains, which 
tend to extend into an all-trans conformation. When they reach the Lα state, the acyl 
chains become shorter, reaching an all-gauche conformation and the packing 
parameter increases between individual lipid molecules (Mok, 1998), also increasing 
their diffusion. The lipid bylayer becomes more fluid and elastic in this state (Ryhänen, 
2006). 
 The transition from gel to fluid state, affects the properties and structure of 
lipid bilayer at the level of lipid acyl chains, individual lipid molecules and at the 
supramolecular assembly as a whole (Ryhänen, 2006).  
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Figure 6.  Lipid bilayer and its transition from gel” state (Lβ) into fluid “liquid crystalline” state 
(Lα) (adapted from Mok, 1998). 
 
 
4. Liposomes 
Liposomes are good models of biological membrane systems to study physical 
properties and functional roles of lipid components. As non-viral vectors, they have 
unique advantages like having diverse morphologies and compositions, different 
release characteristics, lack of immunogenic response, and a low cost production 
(Balazs and Godbey, 2011). They may contain more than one lipid bilayers and so, we 
may classify them into three types: Multilamellar Vesicles (MLVs), Large Unilamellar 
Vesicles (LUVs) and Small Unilamellar Vesicles (SUVs) (Figure 7) 
MLVs can easily be formed upon a lipid film hydration and are usually composed 
of concentric layers of bilayers. The size of this vesicles ranges from 0.5-10 nm, so they 
are very heterogeneous in size (Mayer et al., 1986). MLVs are not widely used for drug 
delivery since they show low trapping volumes. Furthermore their large sizes lead to a 
rapid clearance. However, they can be very useful for studying the structural and 
motional properties of lipids.  
LUVs are vesicles possessing a single bilayer with sizes ranging from 50 to 200 
nm. They can be formed by several methods but the most convenient is extrusion 
through polycarbonate filters with a well defined size pore (Mayer et al., 1986). They 
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show longer circulation lifetimes in vivo due to their smaller size relatively to de MLVs, 
so this makes them a frequently used model for drug delivery.  
SUVs are vesicles composed of a single bilayer with sizes ranging from about 25 
to 50 nm in diameter (Mok, 1998) and can be produced by submitting MLVs to 
sonication (Huang, 1969). 
A method of liposome preparation proposed in order to optimize the properties 
of lipid-DNA complexes consists in both extrusion of the liposomes, so as to obtain 
LUVs, and controlled mixing of lipid and DNA. The results seem to show that the 
lipoplexes exhibit a narrow distribution and small sizes, which might be adequate for 
their in vivo application (Pedroso de Lima et al., 2001). 
 
 
 
 
Figure 7. Multilamellar Vesicles (MLVs), Large Unilamellar Vesicles (LUVs) and Small 
Unilamellar Vesicles (SUVs) (adapted from Mok, 1998). 
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4.1 Cationic lipids and liposomes 
 
There are three parts composing cationic lipids: a hydrophobic anchor, a linker, 
and a head group (Figure 8). 
 
 
 
Figure 8. Scheme exemplifying a cationic lipid (Chestnoy and Huang, 2000). 
 
 
The hydrophobic anchors can be grouped into two major types of hydrophobic 
moieties: aliphatic chains and cholesterol-based derivates. Traditionally, double-tailed 
cationic lipids are more efficient and less toxic than the single tailed cationic lipids 
(Hongtao et al., 2006). So, the majority of synthesized cationic lipids have double chain 
hydrocarbons. Commonly, they are capable of forming liposomes by themselves but it 
is usual to use another phospholipid as helper in the formulations for cationic lipid 
transfections (Chestnoy and Huang, 2000). The length of the alkyl chain in transfection 
activity can also influence the transfection activity (Felgner et al., 1994). 
The linker, as the name states, represents any chemical part between the head 
group and the hydrophobic anchor. This link also plays an important role in gene 
transfer as stated, for example, by Liu (Liu et al., 1997), which concluded that less 
stable ester bonds are not as beneficial as stable ether bonds for in vivo gene transfer. 
As to the head group, cationic lipids may be monovalent or multivalent, 
according to the number of charges. In monovalent lipids, we can find a head group 
consisting of either tertiary or quaternary ammonium groups (Chestnoy and Huang, 
2000). Chemical modifications were also assessed by Felgner (Felgner et al., 1994).  
The cationic nature of the lipid is a determinant factor to its toxicity (Hongtao et 
al., 2006). It is important to state that the definition of a good cationic lipid for gene 
 _________________________________________________________________  Introduction 
 
16 
 
transfer is not a solid one, since their efficiency for in vitro experiments in not 
necessarily the same as for in vivo experiments (Chestnoy and Huang, 2000), and 
further studies must be performed. 
Cationic liposomes may be formed from a single cationic lipid or, as generally 
happens, from a combination of a cationic lipid and a neutral lipid.  They were first 
introduced by Felgner (Felgner et al., 1987) as DNA transfection agents when Felgner 
and colleagues successfully transfected the COS-7 cell line with complexes between 
DNA and 2,3-dioleyloxypropyl-1-trimethyl ammonium chloride (DOTMA) cationic 
liposomes. Since then, new cationic liposome formulations have been reported to 
successfully transfect the cells and some of them have even been commercialized and 
engineered for a wide range of applications (Samad et al., 2007).  
Transfection efficiency varies according to many factors, including the type of 
cationic lipid used or the cell type that is transfected. 1,2-dioleoyl-3-
trimethylammonium-propane (DOTAP) , N [1-(2,3dioleyloxy) propyl]- N,N,N-
trimethylammonium chloride (DOTMA) (Felgner et al., 1987), 
dioctadecyldimetylammonium bromide (DODAB), or synthesized derivatives from 
biologically active compounds including the cationic cholesterol derivatives such as 3β 
[N-(N’,N’- dimethylaminoethane)carbamoyl cholesterol (DC-CHOL) are some examples 
of the cationic lipids used for transfection.  The addiction of a “helper” lipid seems to 
enhance transfection efficiency, although the mechanism responsible for such effect is 
not fully understood. The inclusion of neutral lipids in the liposome formulation 
facilitates the complex fusion to the cellular membrane because they tend to form 
nonbilayer structures which are related to membrane fusion intermediates (Hui et al., 
1996). Dioleyl phosphatidylethanolamine (DOPE), cholesterol and dioleoyl 
phosphatidyl choline (DOPC) are three neutral lipids often incorporated in liposomal 
formulations. The DOPE- containing liposomes, as well as liposomes with some 
galactosydated cholesterol derivates seem to achieve high transfection efficiencies 
regarding human hepatoma cells, Hep 2. They also seem to exhibit low toxicity (Zhang 
et al., 2004). 
In this thesis, various formulations of liposomes composed of 
Dioctadecyldimethylammonium bromide (DODAB), Dioctadecyldimethylammonium 
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chloride (DODAC), 1-monooleoyl-rac-glycerol (MO) and 3β [N-(N’,N’- 
dimethylaminoethane)carbamoyl cholesterol (DC-Chol) are studied.  
Dioctadecyldimethylammonium bromide (DODAB) was first synthesized by 
Kunitake and Okahata (Kunitake and Okahata, 1977), who prepared and characterized 
small unilamellar DODAB vesicles. Since then, Dioctadecyldimethylammonium bromide 
and chloride (DODAB/C) have been prepared through a series of methods in order to 
obtain size-controlled structures with long-term stability for different applications, 
namely as DNA carrier vehicles. They are synthetic lipids that tend to form LUV’s in the 
presence of excess water. These vesicles have their structural organization dependent 
on lipid concentration, the solvent composition, the methods of preparation and the 
temperature. They are also influenced by the presence of other substances (Feitosa et 
al., 2009; Neves Silva et al., 2009).  
Monoolein, 1-monooleoyl-rac-glycerol, is an amphiphilic neutral lipid of natural 
origin. This molecule has the particularity of, even in the presence of excess water, 
presenting two inverted bicontinuous cubic phases (Oliveira et al., 2012). MO has a 
fluidizing effect that seems to contribute to the complexation efficiency of pDNA in 
MO-based lipoplexes in a favorable way (Neves Silva et al., 2008; Neves Silva et al., 
2011; Real Oliveira et al., 2010; Real Oliveira et al., 2011). 
Cholesterol is a neutral lipid and a major component of biological membranes in 
most eukaryotic cells. Cholesterol may act as a “disordering agent” or as an “ordering 
agent”. At high concentration, it can form cholesterol rich domains within the lipid 
bilayer and also condensed complexes or cholesterol crystallites with phospholipids 
(Hungerford et al., 2005; Hungerford et al., 2006). It is frequently used in liposome 
formulations due to its biocompatibility and the stability it confers to lipid membranes 
(Balazs and Godbey, 2011). DC-Chol was first synthesized by Gao and Huang (Gao and 
Huang, 1991). It contains a cholesterol moiety attached by an ester bond to a 
hydrolysable dimethylethylenediamine. DC-Chol was found to have reduced toxicity 
when compared to Lipofectin in some cell lines (Gao and Huang, 1991). It is no surprise 
then, that DC-Chol and other cholesterol derivates have been incorporated in lipoplex 
assembly in order to increase transfection (Balazs and Godbey, 2011; Bennet et al., 
1995).  
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DODAB DODAC MO DC-Chol 
  
 
 
C38H80BrN C38H80ClN C21H40O4 C32H57ClN2O2 
 
Table 1. Structure of the lipids relevant to this study 
 
 
The DODAB:MO system has been previously produced and optimized in order to 
promote transfection in vitro of human cell lines (Neves Silva et al., 2011). The 
exchange of the counter ion in DODAC (Chloride instead of Bromide) might have an 
effect in the colloidal characteristics of the system and affect it’s stability in the 
presence of salt and serum. Also, the inclusion of DC-Chol in the system might have an 
effect on the membranes fluidity, molding it, which should influence the systems 
complexation with the plasmid DNA and, furthermore, its release inside the cell. 
 
5. Lipoplexes 
Both DNA and cationic liposomes suffer structural changes during the 
complexation process (Zhang et al., 2003).  
Cationic lipids interact with negatively charged DNA molecules, which results in 
the formation of DNA/Cationic liposome complexes (lipoplexes). In the complex 
formation, DNA electrostatically binds to the liposome surface and the two 
components rearrange themselves into a new structure. The way lipoplexes interact 
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with the membrane will be influenced by aspects like the presence of specific ligands 
and the vectors overall charge (Chestnoy and Huang, 2000). But the main reaction 
source comes from the positive charge on lipoplex surface which reacts spontaneously 
with the cellular membrane (Zhdanov et al, 2002).  
The study and characterization of the lipid-DNA complexes is very important 
since a better understanding of the assembly of these complexes might help to 
establish a correlation to their biological activity. It is known that the transfection 
efficiency is highly dependent on the structure and properties of a given lipid-DNA 
complex (Chestnoy and Huang, 2000). Indeed Sternberg and colleagues (Sternberg et 
al., 1994), using freeze-fracture electron microscopy, observed different kinds of 
structures of lipoplexes formed between plasmid DNA and cationic liposomes 
composed of DC-Chol and DOPE, depending on the DNA concentration and incubation 
time of the complexes. Experiments performed by Zhang (Zhang et al., 2003) using 
fluorescence resonance energy transfer (FRET) also suggested that the incubation time 
and charge ratio, among other experimental parameters, should be carefully 
controlled in order to achieve optimized transfection activity. 
In the cationic lipoplex structures, DNA might be adsorbed onto the surface of 
the liposome or it might be surrounded by a lipid envelop (Ma et al., 2007). Usually the 
charge ratio (+/−) of the assembled complexes surpasses a value of 1. So we have 
complexes with a positive net charge which promotes an efficient binding with 
negative charges in the cell surface by electrostatic interactions (Hoekstra et al., 2007). 
The fact is, in different lipid mixtures, there has been observed several lipoplex 
morphologies. It has been proposed that some of these structures may correspond to 
metastable intermediates, spaghetti-like structure consisting of double-stranded DNA 
wrapped around the cationic and helper lipids. A lamellar structure, LCα, and hexagonal 
structure, HCII, (Figure 9) are the two symmetries identified as equilibrium ordered 
phases (May et al., 2000).  
The LCα consists of DNA monolayers “sandwiched” between stacked lipid 
monolayers and with intervening water gaps (Figure 9A). The electrostatic attraction 
between the cationic lipid bilayer and the negatively charged DNA confer stability to 
this morphology. Accordingly, the HCII phase may be considered as an ordinary inverse-
hexagonal lipid phase, in which the DNA can be found intercalated within the water 
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tubes (Figure 9B) (May et al., 2000). It has been reports as well of a micellar hexagonal 
phase, HCI (Figure 9C). In this phase the DNA can be found in the interstices of the lipid 
micelle arrangement (Tresset, 2009). 
The concept of lipoplex formation is relatively simple, however, this process can 
determine the morphology and transfection potential of these structures (Ma et al, 
2007). 
  
 
Figure 9. Lipoplex structures. (A) Lamellar phase (LC α); (B) Inverted hexagonal phase (H
C II ); (C) 
micellar hexagonal phase (HCI )(adapted from Tresset, 2009). 
 
 _________________________________________________________________  Introduction 
 
21 
 
6. Outline of this study  
Since their first introduction, cationic lipids have gained a widespread interest as 
a non-viral vector. But they are far from being perfect delivery vectors, and many 
issues are still to be overcome, hence the need for further investigation in this field. 
Based on the DODAB:MO system, previously studied, this work aims to develop 
and characterize a new system, based on DODAC:MO:DC-Chol lipoplexes, suitable to 
perform efficient transfection.  
On a first basis, the aim is to study how the the exchange of the Bromide counter 
ion for the Chloride affects the physical-chemical characteristics of the liposomes and 
the derived lipoplexes. It will be also studied the effect of inclusion of DC-Chol in the 
liposomal formulation. To do so, complexation studies using FRET technique, as well as 
measurements of size and zeta potential of the liposomes and lipoplexes were 
performed. The behavior of the system in the presence of serum and NaCl it was also 
investigated.  
Secondly, the toxicity of the liposomes with different formulations and 
transfection efficiencies of this new system were assessed. 
 
 
 
  
 
  
 _________________________________________________________ Materials and Methods 
 
23 
  
II. Materials and Methods 
 
A) Materials 
Dioctadecyldimethylammonium bromide (DODAB) and 
Dioctadecyldimethylammonium chloride (DODAC) were purchased from Tokyo Kase.  
3ß-[N-(N',N'-dimethylaminoethane)-carbamoyl] cholesterol hydrochloride (DC-
Chol) was purchased from Avanti Polaris Lipids.  
Nucleopore Track-Etch Membranes were purchased from Whatman.  
1-monooleoyl-rac-glycerol (MO), Dulbecco’s Modified Eagle’s Medium (DMEM), 
Antibiotic/Antimycotic solution, Bovine Serum Albumin (BSA), (NADH), The Wizard Plus 
Midipreps DNA Purification System and Bradford reagent were purchased from Sigma-
Aldrich.  
Heat-inactivated Fetal Bovine Serum (FBS), UltraPureTM Salmon Sperm DNA 
solution and rhodamine DHPE were purchased from Invitrogen (UK).  
BOBO-1 was purchased from Molecular Probes (UK). 
 β-Galactosidase Enzyme Assay System with Reporter Lysis Buffer was 
purchased from Promega (USA). 
Opti-MEM I Reduced Serum Medium was purchased from Gibco (UK).  
pSV-β-gal plasmid DNA was kindly offered by the Hematopoietic Biology Unit, 
Faculty of Medicine, University of Lisbon.  
Escherichia coli Xl1-Blue competent cells were kindly given by the Microbiology 
laboratory in the Biology Department of the School of Sciences – University of Minho. 
EzWayTM Transfection Reagent was kindly offered by Koma Biotech. 
 
B) Methods 
 
1. Preparation of liposomes 
1.1 Ethanolic injection 
One of the methods used to produce liposomes was ethanolic injection. 
Defined volumes taken from stock solutions of DODAB/C, MO, and DC-Chol (20mM) in 
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ethanol were dissolved in a know amount of ethanol (organic solvent) and injected in a 
volume of distilled water, preheated to 50ºC, under vigorous vortexing. The organic 
solvent evaporates when it comes into touch with the distilled water due to the heat. 
So we obtained an aqueous solution of liposomes DODAB/C:MO:DC-Chol (ratios 6:3:1, 
5:4:1, 4:1:1) and DODAB/C:MO (2:1) at a final concentration of 1mM , mostly 
composed of multivesicular liposomes. 
 
1.2 Film hydration method 
Again, defined volumes taken from the lipids stock solution of DODAB/C, MO, 
and DC-Chol (20mM) in ethanol were placed in a rotary evaporator (Heidolph VV Micro 
Rotary Evaporator). The organic solvent was then evaporated under vacuum and at 
50ºC, safely above the lipids phase transition temperature, until all traces of organic 
solvent were gone and a lipidic film was formed. The resulting lipidic film was then 
dispersed in a given volume of ultra-pure water in order to obtain a solution with 
liposomes DODAB/C:MO:DC-Chol (ratios 6:3:1, 5:4:1, 4:1:1) and DODAB/C:MO (ratios 
2:1) with a final concentration of 1mM.    
 
1.3 Extrusion 
The solution containing the liposomes obtained from the film hydration 
method was placed in the extruder (Northern Lipids Lipex Extruder). Under a 4-8bar 
pressure, the liposomes were forced to pass trough polycarbonate filters (Whatman) 
with a defined pore size. In this case, the liposomes were submitted to one passage 
through a filter with a pore size of 400nm and then four passages through a filter with 
a pore size of 100nm. The mean diameter of the obtained population reflects the 
diameter of the used filter pore, and unilamellar vesicles were obtained. This process 
was carried out at 50ºC so that the lipids were in a fluid state and preventing, in this 
way, as much retention of lipid in the filters as possible. 
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2. Preparation of DNA solutions 
2.1 Plasmid DNA 
2.1.1 Transformation of competent cells 
Plasmid DNA (pSV-β-Galactosidase control vector) was added to a 200µL 
aliquot of Escherichia coli Xl1-Blue competent cells and the mixture swirled and 
incubated on ice for 30 minutes. The mixture was heat-pulsed with occasional 
agitation at 42 ºC for 90 seconds, and placed on ice for 10 min. Then 800µL of SOC 
medium (2% tryptone peptone, 0.5% yeast extract, 2.5mM KCl, 10mM NaCl , 10mM 
MgSO4, 10mM MgCl2, 20mM glucose) was added and the tubes were incubated at 37ºC 
at 200 rpm, for 1 hour. The cells were then centrifuged at 14000 rpm for less than 10 
seconds and the pellet resupended in 50µL of supernatant. The resuspended pellet 
was then  pipetted  to a petri dish with  LB medium (1 % tryptone peptone, 0.5 % yeast 
extract, 1 % NaCl, 2 % agar) supplemented with ampicillin (100µg/µL) and spread 
gently and minimally using a bent (L-shaped) Pasteur pipette. A petri dish with 
competent cells not submitted to the transformation process was also used as control. 
These plates were incubated at 37ºC to establish colonies. Only transformed cells will 
form colonies since this strain is susceptible to ampicillin and the plasmid confers 
resistance to the cells. Once the colonies are grown, one of them is selected and 
transferred into 200mL of LB medium (1 % tryptone peptone, 0.5 % yeast extract, 1 % 
NaCl) at 37ºC at 200rpm overnight. This overnight recombinant E. coli culture is then 
harvested in order to isolate the plasmid DNA. 
 
2.1.2 Purification of plasmid DNA 
Wizard® Plus Midipreps DNA Purification System (Promega Madison, USA) was 
used to isolate the pSV-β-Galactosidase control vector from Echerichia coli Xl1-Blue. 
The isolated plasmid DNA was then ressuspended in ultra-pure water and measured 
with NanoDrop ND 100 Spectrophotometer in order to verify it’s purity by the 
determination of the ratio absorbance at 260/280nm. 
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2.2 Salmon Sperm DNA solution 
Salmon sperm DNA solution was prepared in PBS buffer (10mM, pH 7.4) to a 
final concentration of 5×10-4 M from a stock solution (10mg/mL) of UltraPure™ Salmon 
Sperm DNA Solution (Invitrogen). 
 
3. Preparation of lipoplexes 
The DNA concentration used for cell transfection and lipoplex cytotoxicity 
assays was 1ug/ul and for the complexation and stability studies was 20ug/ul. The 
balance between charges is given by the charge ratio (+/-): 
 
          
   
   
 
                                                
                          
 
 
The positive charges are given by the concentration of ammonium groups 
present in DODAB/C and amine present in DC-Chol. The negative charges are given by 
the concentration of phosphate groups in DNA, which correspond to the nucleotide 
concentration. 
For the mean size measurements, DODAC:MO:DC-Chol (ratios 6:3:1, 5:4:1, 
4:1:1) and DODAB/C:MO (ratio 2:1) were added in a single step, at 25ºC, to sperm 
salmon DNA (20ug/ul), forming lipoplexes with charge ratios (+/-) of 0.5, 1.0, 1.5, 2.0, 
3.0, 4.0. The addition was followed by a 5 minutes agitation period. Size 
measurements and Zeta Potential determination of the lipoplexes were performed 
after 1h of incubation. 
For the FRET assay, liposomes were incubated with rhodamine DHPE (5×10-5 M) 
at a 1:200 ratio during their preparation by the film hydration method followed by 
esxtrusion, as previously described. The Salmon sperm DNA (20µg/µL) was also 
incubated with BOBO-1 probe (2×10-5 M). The lipoplex preparation method and the 
liposome formulations used were the same as the ones produced for the complexation 
studies forming lipoplexes with charge ratios (+/-) of 0.25, 0.5, 0.75, 1.0, 1.5, 2.0, 2.5, 
3.0 and 4.0. 
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For stability studies, the lipoplex formation procedure and the used liposome 
formulations were the same as described before, except for the generated charge 
ratios (+/-), which was 4.0. 
The liposomes used to form the DNA-liposome complexes for the complexation 
assays, FRET assay and stability studies were produced only by the film hydration 
method followed by extrusion. 
For the transfection and cytotoxicity assays, lipoplexes were generated at a 
charge ratio (+/-) of 4.0 and plasmid DNA (1µg/µL) was used. The liposomes used in 
the production of these complexes were produced by the ethanolic injection and the 
film hydration method described previously and the used formulations were 
DODAB/C:MO:DC-Chol (ratios 6:3:1, 5:4:1, 4:1:1) and DODAB/C:MO (ratio 2:1). 
 
4. Dynamic Light Scattering and Zeta potential measurements 
4.1 Dynamic Light Scattering (DLS) assays 
Dynamic Light Scatering (or PCS - Photon Correlation Spectroscopy) is a 
technique that measures the Brownian motion of the particles by illuminating them 
with a laser and analyzing the intensity fluctuations in the scattered light, relating 
these measurements to the size of the particles. It can also give us information about 
the homogeneity of the sample (Malvern, 2005). Particles suffer random movement in 
a liquid due to the surrounding molecules which bombard them and this random 
movement is defined as the Brownian motion. The speed of movement is used to 
determine the size of the particle. A laser beam is used to irradiate the randomly 
moving particles in order to record the intensity of the light scattered in a fixed or 
variable angle and in given time interval. Smaller particles move faster, so they lead to 
faster intensity fluctuations due to their high diffusion coefficient. Larger particles 
move slower, is manifested in slower intensity fluctuations. (Clark et al, 1970; Malvern, 
2005). 
The Stokes-Einstein equation defines the relationship between the particle size 
and its speed due to the Brownian motion: 
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Where (D) is the particle diffusion coefficient, (K) the Boltzmann constant, (T) 
the temperature, (R) the radius of the particle and (η) the medium viscosity 
The Polydispersity index (PDI) is an indicative of the heterogeneity degree 
regarding to the sample size. The PDI values ranges between 0.0 and 1.0 and depend 
on the range of diameters found between the average diameter. The greater this 
range of diameters is, the higher the standard deviation, thus, the greater is the PDI 
(Malvern, 2005). 
Measurements of particle size and PDI were performed using a Malvern 
zetasizer Nano SZ particle analyzer (Malvern Instruments). 
 
4.2 Mean size of liposomes 
1 mL solutions of DODAB/C:MO (2:1), DODAC:MO:DC-Chol (DODAC:MO (2:1) 
with 10%, 20%, 30%, 40% and 50% of DC-Chol) and DODAB/C:MO:DC-Chol (ratios 
6:3:1, 5:4:1, 4:1:1) liposomes, produced by ethanolic injection and the film hydration 
method followed by extrution, were placed in disposable polystyrene cuvettes 
(Sarstedt, Germany) for DLS measurements. These measurements were performed at 
25ºC in a Malver ZetaSizer Nano SZ particle analyser. The Malvern Dispersion 
Technology Software (DTS) was used and mean size (nm) average, polydispersity index 
and error values were taken in consideration.   
 
4.3 Mean size of lipoplexes 
1 mL solutions with DNA/DODAB/C:MO (2:1) and DNA/DODAC:MO:DC-Chol 
(ratios 6:3:1, 5:4:1, 4:1:1) lipoplexes at charge ratios (+/-) 1.0,1.5, 2.0,3.0 and 4.0 were 
placed in disposable polystyrene cuvettes (Sarstedt, Germany) for DLS measurements, 
which were executed in a Malver ZetaSizer Nano SZ particle analyser, at 25ºC. The 
mean size (nm) average, polydispersity index and error values were taken in 
consideration and data was analyzed with Malvern Dispersion Technology Software 
(DTS). 
 
 
 
 _________________________________________________________ Materials and Methods 
 
29 
 
4.4 Stability studies 
4.4.1 Stability in serum 
Solutions of DODAC:MO:DC-Chol (ratios 6:3:1, 5:4:1, 4:1:1) and DODAB/C:MO 
(2:1) liposomes, prepared by the film hydration method, described previously, were 
incubated in 0, 30 and 80% of FBS (Fetal Bovine Serum) and were placed in disposable 
polystyrene cuvettes for DLS measurements. The same procedure was repeated for 
DNA/DODAC:MO:DC-Chol (ratios 6:3:1, 5:4:1, 4:1:1) and DNA/DODA(X):MO (2:1) 
lipoplex solutions at charge ratio (+/-) 4.0. The measurements were executed at 
different time points: 0h, 3h, 6h and 24h. The cuvettes were placed in a Malver 
ZetaSizer Nano SZ particle analyser and again, the Malvern Dispersion Technology 
Software (DTS) was used and mean size (nm) average, polydispersity index and error 
values were taken in consideration. 
   
4.4.2 Stability in NaCl 
Solutions of DODAC:MO:DC-Chol (ratios 6:3:1, 5:4:1, 4:1:1) and DODAB/C:MO 
(2:1) liposomes, prepared by the film hydration method followed by extrusion, as 
described above, were incubated with different volumes of a NaCl solution (3.84M) in 
order to obtain different final concentrations of this salt (0, 5, 10, 50, 100 and 150 
mM). The same procedure was applied to the lipoplex solutions. The 
DNA/DODAC:MO:DC-Chol (ratios 6:3:1, 5:4:1, 4:1:1)/DNA complex and 
DNA/DODAB/C:MO (2:1)/DNA complex solutions at charge ratio (+/-) 4.0, were 
incubated with the same NaCl solution as the liposomes in order to obtain lipoplex 
solutions incubated with different concentrations of NaCl (0, 5, 10, 50, 100 and 150 
mM). The samples were placed in disposable polystyrene cuvettes for DLS 
measurements which took place 1h after incubation. The cuvettes were placed in a 
Malver ZetaSizer Nano SZ particle analyser and again, the Malvern Dispersion 
Technology Software (DTS) was used and mean size (nm) average, polydispersity index 
and error values were taken in consideration.   
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5. Zeta (ζ) Potential assays 
The zeta potential is a physical property found in particles in suspension. When 
in contact with a liquid, particles tend to acquire an electrical charge on their surface. 
There is an electrical double layer surrounding each particle in suspension. There are 
two parts of this layer: the stern layer, where the ions are strongly bound, and the 
diffuse layer where the ions are not so firmly attached (Figure 10). In this last layer, 
there is a boundary where the ions and particles form a stable entity. When the 
particle moves, only the ions within this boundary, the slipping plane, move with it. 
The potential in the slipping plane is known as the zeta potential (Malvern, 2005). 
 
 
 
Figure 10. Schematic representation of the double layer surrounding a particle in suspension 
(Malvern, 2005).  
 
 
The zeta potential is not obtained by a direct measurement.  It is calculated by 
the determination of the electrophoretic mobility, obtained by performing 
electrophoresis experiments on the samples and executing measurements of the 
particles velocity using Laser Dopller Velocimetry (LDV), and then applying the Henry 
equation: 
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where, μe is the electrophoretic mobility, the zeta (ζ) potential, ε is the 
dielectric constant, f (Ka) is the role of Henry and η is the viscosity of the medium 
(Malvern, 2005). 
The electrophoretic mobility is measured by applying an electric field. The 
potential difference created by the opposite charges in the two electrodes makes the 
charged particles that exist in suspension move to the electrode of opposite charge. 
The particles will move with a constant velocity when equilibrium between these two 
forces is reached. The velocity at which the particles move in an electric field is known 
as electrophoretic mobility. This velocity is measured by Laser Dopller Velocimetry 
(LDV) (Malvern, 2005). 
 
5.1 Zeta potential of the liposomes 
1 mL solutions of DODAB/C:MO (2:1) and DODA(X):MO:DC-Chol (ratios 6:3:1, 
5:4:1, 4:1:1) liposomes were placed in 0.7ml universal dip cells for ζ-potential 
measurements, which took place at 25ºC in a Malver ZetaSizer Nano SZ particle 
analyzer. The Malvern Dispersion Technology Software (DTS) was run with monomodal 
mode data processing and ζ-potential (mV) average and error values were taken into 
consideration. 
 
5.2 Zeta potential of lipolplexes  
1 mL solutions of DNA/DODAB/C:MO (2:1) and DNA/DODAB/C:MO:DC-Chol 
(ratios 6:3:1, 5:4:1, 4:1:1) lipoplexes at charge ratios (+/-) 0.5, 1.0, 1.5, 2.0, 3.0 and 4.0 
were placed in 0.7ml universal dip cells (Malvern Instruments) for ζ-potential 
measurements, which were executed in a Malver ZetaSizer Nano SZ particle analyzer, 
at 25ºC. The Malvern Dispersion Technology Software (DTS) was run with monomodal 
mode data processing and ζ-potential (mV) average and error values considered. 
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5.3 Stability studies 
5.3.1 Stability in NACl 
Solutions of DODAC:MO:DC-Chol (ratios 6:3:1, 5:4:1, 4:1:1) and DODAB/C:MO 
(2:1) liposomes, prepared by the film hydration method followed by extrusion as 
described above, were incubated with different volumes of a NaCl solution (3.84M) in 
order to obtain different final concentrations: 0, 5, 10, 50, 100 and 150 mM. For 
DNA/DODAC:MO:DC-Chol (ratios 6:3:1, 5:4:1, 4:1:1) and DNA/DODAB/C:MO (2:1) 
lipoplex solutions at charge ratio (+/-)4.0, it was applied the procedure previously 
described for the liposome solutions. The samples were placed in 0.7ml universal dip 
cells (Malvern Instruments) for ζ-potential measurements which took place 1h after 
incubation. The cells were placed in a Malver ZetaSizer Nano SZ particle analyser and 
again, the Malvern Dispersion Technology Software (DTS) was used and and ζ-potential 
(mV) average and error values were taken in consideration 
 
6. Fluorescence Resonance Energy Transfer (FRET) assay 
FRET is a technique that can describe energy transfer between two 
chromophores. There is an energy transfer between a donor chromophore, initially in 
its electronic exited state, and an acceptor chromophore. The amount of energy 
transfer is dependent on the distance between the two chromophores.Also the 
absorption spectrum of the acceptor must overlap with the emission spectrum of the 
donor in order for the non-radiative transfer of excitation energy occurs (Figure 11). 
This way, several vibronic transitions in the donor and the acceptor have practically the 
same energy (Valeur, 2001). Other criterion that must be satisfied for FRET to occur 
are that the donor and the acceptor must have approximately parallel transition dipole 
orientations and that the donors fluorescence lifetime must have a sufficient duration 
in order to allow the FRET to occur (Piston et al., 1948; Valeur, 2001). 
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Figure 11. Donor (BOBO-1) and acceptor (rhodamine-DHPE) spectrums with the spectral 
overlap integral between the emission spectrum of the donor and the absorption of the 
acceptor. (adapted from: 
http://www.invitrogen.com/site/us/en/home/support/ResearchTools/Fluorescence-
SpectraViewer.html 
 
 
FRET is widely used to measure distances between donors and acceptors in 
macromolecular systems. The efficiency process depends on the inverse sixth distance 
between the donor and acceptor.  
E = Ro6/(Ro6 + r6) 
Where Ro is the critical radius of Förster, which can be defined as the distance 
at which half the energy is transferred and r is the actual distance between donor and 
acceptor. So, it’s easy to see that the distance affects greatly the efficiency of energy 
transfer. The critical radius of Förster (R0) can be estimated by: 
R0 (nm) = 979 (κ
2 η4 φ0 ζ)
1/6  
Where η is the refractive index of the medium, φ0 is the fluorescence quantum 
yield of the donor, ζ the spectral overlap integral and κ an orientation factor. 
The energy transfer rate (ΦFRET) can be determined by: 
ΦFRET = 1/τd (R0/r)
6 
Where τd is the decay time of the donor fluorescence in the absence of an 
acceptor and r is the distance between donor and acceptor.  
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This assay was executed by monitoring the decrease of fluorescence of BOBO-1 
(donor) in the presence of rhodamine DHPE (acceptor) in a Horiba Jobin Yvon Spex 
Fluorolog spectrofluorimeter after the addition of the cationic liposomes to the DNA 
solutions, followed by a 5 minutes agitation period with a magnetic stirrer. The 
fluorescence intensities were determined at λexc = 460 nm with spectral bandwidths of 
1 nm. All emission spectra were integrated, and the ratio of the areas for the dye 
solutions were determined. The fluorescence resonance energy transfer efficiency 
(ФFRET) was determined from the following expression: 
(ФFRET)= (1- F(DA) / F(D))*100 
Where F(DA) and F(D) are the fluorescence emission of donor in the presence and 
absence of acceptor, respectively. 
 
7. Cell Culture 
The 293 T and L929 cell lines were cultured in DMEM medium supplemented 
with 10% (v/v) heat-inactivated FBS and 1% (v/v) of an antibiotic/antimycotic solution, 
with 5 % CO2 at 37 ºC. 
 
7.1 MTT assay 
This technique involves the use of MTT (3,(4,5-dimethylthiazol-2-yl)-2,5-
diphenyl tetrazolium bromide)) which is a tetrazolium salt. This salt is metabolized by 
mitochondrial enzyme activity in living cells, forming an insoluble coloured formazan 
salt, thus being a rapid colorimetric method to assess cell viability (Masters, 2000). 
Briefly, after an incubation period of 48h, the culture medium was replaced by 
fresh medium to which it was added 50µL of MTT 10x to each well. Cell cultures were 
then incubated for 2h in a humidified incubator at 37ºC, with 5% CO2. Then, the 
culture medium containing MTT was removed and it was added to each well 500µL of 
a DMSO/ethanol solution (1:1(v/v)), followed by a slight agitation of the plate in order 
to facilitate the dissolution of the crystals. It was taken from each well 150µL of the 
solution containing the dissolved crystals and it was placed in a 96 well reading plate in 
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order to read the optical density at 570nm in a microplate reader SpectraMax Plus 
(Molecular Devices, USA). The DMSO/ethanol solution (1:1(v/v)) was used as blank. 
 
7.2 LDH (lactate dehydrogenase) assay 
This technique allows us to make an indirect measurement of cell viability. LDH 
is a quantitative measurement of cell viability loss since it is released by dead or dying 
cells. LDH measurement basically follows the oxidation of NADH, which is initiated by 
the addition of pyruvate, by the change of absorbance at 340nm. These measurements 
are performed in a cell-free medium at a temperature of 30ºC (Masters, 2000). 
So, after a 48h incubation period, the cell culture medium from each well was 
collected to individual eppendorfs in order to determine extracellular LDH. The 
eppendorfs were then centrifuged at 13000rpm for 1 minute in order avoid having 
cells or cellular fragments in suspension and the supernatant was collected to fresh 
eppendorfs. Then, 40 µl of supernatant were placed in a 96 well reading plate, along 
with 250ul of NADH solution (0.3mM in phosphate buffer 0.05M, pH 7.4) and 10 µl of 
pyruvate solution (0.05M in phosphate buffer 0.05M, pH 7.4) in each well. The 
pyruvate solution was added immediately before performing the optical density 
reading in a multiwall plate reader. The readings were executed at 30ºC in intervals of 
10 seconds for 3 minutes at 340nm in a microplate reader SpectraMax Plus (Molecular 
Devices, USA). 
 
7.3 Cytotoxicity assay 
Cytotoxicity was assessed by MTT assay and by the measurement of 
extracellular Lactate Dehydrogenase (LDH), after a 48h hour period of incubation with 
the liposomes and lipoplexes.  The 293T cell line was used to evaluate the cytotoxicity 
of the lipoplexes and the L929 cell line was used to evaluate liposome cytotoxicity. 
Cells were cultured in 24-well culture plates (TPP, Trasadingen, Switzerland) at 
a density of 3×104 cells per well and 1×105 cells per well for liposomes and lipoplexes 
respectively. The cell culture medium was removed and replaced with fresh medium 
immediately before the liposomes and lipoplexes addition. To the plaque with the 
L929 cell line, it was added to each well the liposome solution of interest (buffered 
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with PBS 1x, pH 7.4) with different concentrations. For the DODAB/C:MO:DC-Chol 
(ratios 6:3:1, 5:4:1, 4:1:1) and DODAB/C:MO (ratio 2:1) the final concentrations were 5, 
50 and 100 ug/ml. Cells incubated with DMSO (30% of the total volume), a volume of 
PBS solution (1x, pH 7.4) corresponding to the volume added for the maximum 
concentration of liposomes for each formulation and cells without the addition of any 
compounds were used as controls. To the plaque with 293T cell line, 100 µL of lipoplex 
solution prepared in Opti-MEM (Gibco) was added to each well, in duplicate. The 
lipoplexes used were obtained from the addition to DNA of the same liposome 
formulations used for the transfection experiments, with a charge ratio (+/-) of 4.0. 
Cells incubated with DMSO (30% of the total volume) and cells without the addition of 
the compounds were used as controls. Cell cultures were then maintained in a 
humidified incubator, with 5% CO2, at 37ºC for 48h. After that period of incubation, 
the extracellular LDH and the MTT assays were performed in a microplate reader 
SpectraMax Plus (Molecular Devices, USA). 
 
7.4 Transfection 
293T cells were seeded into 24-well plates (TPP, Trasadingen, Switzerland), at a 
density of 1×105 cells per well. Just before adding to each well 100µl of the lipoplex 
solutions prepared in Opti-MEM (Gibco), the cell culture medium was replaced by 
fresh medium. The cells cultures were kept in a humidified incubator with 5% CO2, at 
37ºC. EzWay transfection agent (Koma Biotech) was also used to carry out DNA 
transfection, and used according to the manufacturer’s instructions. After 48h, the β-
galactosidase expression was evaluated with the β-Galactosidase Enzyme Assay 
System with Reporter Lyses Buffer (Promega), according to the standard given 
protocol. The amount of protein in each sample was also quantified by the Bradford 
method to normalize for varying cell numbers resulting, for example, of cytotoxicity. 
 
7.5 Bradford protein quantification assay 
This is a method that allows protein determination by the binding of Coomassie 
Brilliant Blue G-250 to the proteins. The dye has two forms: blue and red form. When 
the dye binds to a protein, it will cause a shift of the absorption maximum of the dye 
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from 465nm to 565 nm, and the red form of the dye is converted in the blue form. An 
excess amount of dye is added to the protein samples and the absorption at 595nm is 
measured. As control, protein standards are used, enabling the determination of the 
amount of protein in unknown samples (Bradford, 1976).  
Briefly, a standard curve was made by preparing samples of BSA with final 
concentrations of 0, 0.25, 0.5, 0.5, 1 and 2 mg/mL and 10µL of each of these samples 
with different concentrations were added to individual wells in a 96 well reading plate. 
The same procedure was applied to the samples with unknown amount of proteins. 
Then, 250uL of Bradford reagent was added to each well and the contents mixed by 
vortexing. The absorbance at 595nm was measured after 5 minutes in a microplate 
reader SpectraMax Plus (Molecular Devices, USA) against a reagent blank prepared 
from the Reporter Lyses Buffer (RLB) solution (Promega).  
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III. Results and Discussion 
 
1. Dynamic Light Scattering (DLS) assays 
One of the main of this work was to study how the counter ion exchange 
(Bromide or Chloride), the preparation method (ethanolic injection and film hydration 
followed by extrusion) and also the inclusion of DC-Cholesterol affects the mean size 
and charge of the DODAB/C:MO based  liposomes and (DODAB/C:MO:pDNA) 
lipoplexes. 
 
1.1 Mean size of liposomes 
 
As reported in previous work by Neves Silva, lipoplexes based DODAB:MO (2:1) 
liposomes prepared by ethanolic injection have shown good transfection efficiency 
(Neves Silva et al., 2011) the DODAB:MO (2:1) formulation was chosen to be used as 
means of comparison in this work.  
The figure 12 presents the mean size and PDI for DODAB:MO (2:1) and 
DODAC:MO (2:1) liposomes prepared by two preparation methods. 
 
B:
M
 (2
:1
)
C:
M
 (2
:1
)
0.0
0.2
0.4
0.6
0.8
P
D
I
B:
M
 (2
:1
)
C:
M
 (2
:1
)
0
100
200
300
400
M
e
an
 s
iz
e
 (
n
m
)
Liposomes DODAB/C:MO (2:1)
Ethanolic injection
Film hydration and extrusion
 
Figure 12. Mean size and Polidispersity index (PDI) of DODAB/C:MO (2:1) liposomes produced 
by ethanolic injection and Film hidration method followed by extrusion. B:M (2:1) – 
DODAB:MO liposomes with 2:1 ratio; C:M (2:1) – DODAC:MO liposomes with 2:1 ratio. 
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It seems that the liposomes prepared by the extrusion method, show no 
significant differences in the mean size or in the PDI of the populations of DODAB:MO 
and DODAC:MO liposomes, although DODAB:MO liposomes present slightly larger 
mean size and PDI values (132.8 nm and 0.085 respectively) compared with the 
DODAC:MO vesicles (109.5 nm and 0.071 respectively).  
Regarding to liposomes produced by ethanolic injection, DODAB:MO liposomes,  
seem to present a higher mean size (~270nm) compared with DODAC:MO (~74nm). 
although both formulation present  high PDI values  
From figure 12 it can be observed that DODAB:MO liposomes prepared by 
ethanolic injection present higher mean size than the DODAB:MO liposomes  prepared 
by extrusion, however, for DODAC:MO liposomes the opposite effect is observed. 
These changes could be related with the type of liposomes prepared by the two 
methods. It is important to note that the liposomes produced by ethanolic injection 
are multivesicular liposomes as opposed to the ones produced by film hydration and 
submitted to extrusion, which are unilamellar. 
The measurements performed with extruded liposomes indicated the presence 
of only one population, as it was to be expected, hence the low PDI values but for 
liposomes produced by ethanolic injection three different populations were observed 
(see Appendix 1). It should be noticed that the main population found in DODAB:MO 
liposomes produced by ethanolic injection was about 246nm, still higher than the main 
population found in DODAC:MO lipossomes produced by the same method, which was 
around 181 nm (see Appendix 1). But the value of the main population of DODAC:MO 
liposomes produced by ethanolic injection is higher than the value registered for the 
mean size using DODAC:MO liposomes produced by the extrusion method 
 It seems that the exchange of the counter ion Bromide with Chloride influences 
the size of the liposomes produced by both methods, making them smaller. 
These results come in line with results obtained previously on the investigation 
of extruded vesicles of DODAB and DODAC where the authors explain that this 
difference in vesicle size might be explained by the specificity of the counterion 
binding to the vesicle interfaces (Lopes et al., 2008). This data is also in agreement with 
reports for spontaneous, injected and sonicated dispersions. The specificity of counter 
ion binding is also reflected in Tm . Bromide binds DODAB vesicles yelding larger 
 _________________________________________________________  Results and Discussion 
 
41 
 
vesicles with lower curvature and Tm than DODAC vesicles. This means that DODAB 
vesicles present a more densely packed bilayer, which allows Bromide to bind more 
tightly to the vesicle interfaces than Chloride (Feitosa et al., 2000) 
 
1.1.1 Effect of DC-Cholesterol 
In light of these results, it was decided to study  the effect of the inclusion of 
DC-Chol on the mean size and PDI of DODAC:MO (2:1) liposomes, prepared by 
extrusion method, with 10%, 20%, 30%, 40% and 50% of DC-Chol.These results are 
represented in figure 13. 
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Figure 13. Mean size and polidispersity index of DODAC:MO (2:1) extruded liposomes with 
diferente percentages of DC-Chol (B). Control: DODAC:MO (2:1) liposomes. 
 
 
According to these results, the inclusion of different percentages of DC-Chol in 
the DODAC:MO system doesn’t alter significantly the size or the PDI of extruded 
vesicles. 
Since the inclusion of DC-Chol in the formulation has the purpose molding the 
membranes fluidity and eventually aid in an enhancement of transfection efficiency, it 
was decided not to include high percentages of DC-Chol in the system, since it has 
 _________________________________________________________  Results and Discussion 
 
42 
 
been shown before that high levels of cholesterol in the liposomal formulation lead to 
the formation of rigid domains (Hungerford et al., 2005), altering the systems fluidity.   
Taking this in mind it was decided to include 10% and 16% of DC-Chol in the 
studied formulations. So, the formulations DODAB/C:MO:DC-Chol in the molar ratios 
of 6:3:1, 5:4:1, 4:1:1 will be studied.  
The Figure 14 presents the mean size and PDI of liposomes composed by 
DODAB/C:MO:DC-Chol in the molar ratios of 6:3:1, 5:4:1, 4:1:1, produced by the 
ethanolic injection method and film hydration method followed by extrusion 
compared with the DODAB/C:MO (2:1). 
The inclusion of cholesterol in the DODAC:MO formulation prepared by the two 
preparation methods (ethanolic vs extrusion) does not promotes a great change in the 
mean size of the liposomes. Again, the liposomes prepared by the ethanolic injection 
presenting a very high PDI. The formulation 6:3:1 was the one that present a higher 
mean size. 
Moreover, it is important to refer that the readings performed to ethanolic 
injection liposomes showed the presence of more than one population, thus explaining 
the high values of PDI (see Appendix 1). Also important is that this mean size represent 
a virtual value, since there are populations of various sizes found in solution for 
liposomes produced by ethanolic injection. 
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Figure 14. Mean size (A) polidispersity index (B) of DODAB/C:MO (2:1) and DODAB/C:MO:DC-
CHOL  (6:3:1, 5:4:1 and 4:1:1) liposomes produced by ethanolic injection and by film hydration 
followed by extrusion. B:M:D (6:3:1) – DODAB:MO:DC-Chol liposomes with 6:3:1 ratio; C:M:D 
(6:3:1) – DODAC:MO:DC-Chol liposomes with 6:3:1 ratio; B:M:D (5:4:1) – DODAB:MO:DC-Chol 
liposomes with 5:4:1 ratio; C:M:D (5:4:1) – DODAC:MO:DC-Chol liposomes with 5:4:1 ratio; 
B:M:D (4:1:1) – DODAB:MO:DC-Chol liposomes with 4:1:1 ratio; C:M:D (4:1:1) – 
DODAC:MO:DC-Chol liposomes with 4:1:1 ratio. 
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1.1.2 Stability in time of liposomes and lipoplexes 
In order to know how the preparation methods affect the liposomes stability 
with the course of time, measurements of particle size were performed throughout 
time.  
As it can be observed in figure 15, the liposomes produced by film hydration 
followed by extrusion are very stable, maintaining a constant size along time. The PDI 
also doesn’t suffer changes through time (see Appendix 2).  
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Figure 15. Comparison of the mean size of DODAB/C:MO (2:1) and DODAB/C:MO:DC-CHOL 
(6:3:1, 5:4:1 and 4:1:1) liposomes produced by ethanolic injection  and by film hydration 
followed by extrusion over 9 weeks. B:M (2:1) – DODAB:MO liposomes with 2:1 ratio; C:M 
(2:1) – DODAC:MO liposomes with 2:1 ratio; B:M:D (6:3:1) – DODAB:MO:DC-Chol liposomes 
with 6:3:1 ratio; C:M:D (6:3:1) – DODAC:MO:DC-Chol liposomes with 6:3:1 ratio; B:M:D (5:4:1) 
– DODAB:MO:DC-Chol liposomes with 5:4:1 ratio; C:M:D (5:4:1) – DODAC:MO:DC-Chol 
liposomes with 5:4:1 ratio; B:M:D (4:1:1) – DODAB:MO:DC-Chol liposomes with 4:1:1 ratio; 
C:M:D (4:1:1) – DODAC:MO:DC-Chol liposomes with 4:1:1 ratio. 
 
 
The ethanolic injection liposomes are not stable during long periods of time 
though. In fact, the mean size of the mean size decreased in all formulations but the 
PDI value increased (see Appendix 2). This behavior may be possibly due to the fusion 
of the multivesicular vesicles. 
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1.2 Mean size of lipoplexes 
Figures 16 and 17 present the mean size and polidispersity index (PDI) of 
lipoplexes prepared using salmon sperm DNA and DODAB/C:MO (2:1) and 
DODAC:MO:DC-Chol (6:3:1, 5:4:1, 4:1:1) liposomes produced by the extrusion method. 
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Figure 16. Mean size of :(A) DNA/DODAB/C:MO (2:1) lipoplexes; (B) DNA/DODAC:MO (2:1) and 
DNA/DODAC:MO:DC-Chol (6:3:1, 5:4:1 and 4:1:1) lipoplexes at different charge ratios (+/-). 
DNA/B:M (2:1) – DNA/DODAB:MO (2:1) lipoplexes; DNA/C:M (2:1) – DODAC:MO (2:1) 
lipoplexes; DNA/C:M:D (6:3:1) – DNA/DODAC:MO:DC-Chol (6:3:1) lipoplexes; DNA/C:M:D 
(5:4:1) – DNA/DODAC:MO:DC-Chol (5:4:1) lipoplexes; DNA/C:M:D (4:1:1) – 
DNA/DODAC:MO:DC-Chol (4:1:1) lipoplexes. 
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The PDI values also seem to follow the tendency observed for the mean size 
values (Figure 17). 
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Figure 17. Polidispersity index of :(A) DNA/DODAB/C:MO (2:1) lipoplexes; (B) DNA/DODAC:MO 
(2:1) and DNA/DODAC:MO:DC-Chol (6:3:1, 5:4:1 and 4:1:1) lipoplexes at different charge ratios 
(+/-). DNA/B:M (2:1) – DNA/DODAB:MO (2:1) lipoplexes; DNA/C:M (2:1) – DODAC:MO (2:1) 
lipoplexes; DNA/C:M:D (6:3:1) – DNA/DODAC:MO:DC-Chol (6:3:1) lipoplexes; DNA/C:M:D 
(5:4:1) – DNA/DODAC:MO:DC-Chol (5:4:1) lipoplexes; DNA/C:M:D (4:1:1) – 
DNA/DODAC:MO:DC-Chol (4:1:1) lipoplexes. 
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It can be observed a great increase in mean size with the increase in CR (+/-) 
followed by a decrease in mean size. This increase in the mean size is different for each 
formulation. 
DNA/DODAC:MO (2:1) reaches the higher size at the charge ratio (+/-) 1.5  
compared with pDNA/DODAB:MO (2:1) and this occurs at the charge ratio (+/-) 2.0. 
Again the lipoplexes obtained from DODAC:MO (2:1) liposomes are smaller than 
lipoplexes obtained from DODAB:MO (2:1) liposomes at the charge ratios (+/-) 3.0 and 
4.0  . 
For DNA/DODAC:MO:DC-Chol (5:4:1) complexes the increase in size occurs at 
the charge ratio (+/) 1.0 compared with pDNA/DODAC:MO:DC-Chol (6:3:1) and (4:1:1) 
complexes that occurs at charge ratio (+/-) 1.5. The mean size of the lipoplexes at the 
charge ratios (+/-) 3.0 and 4.0 are similar for all the formulations. (Figure 16).  
The increase in size at a specific charge ratio (+/-) is associated with the point at 
which is reached an isoelectric point.  
 At charge ratios (+/-) 3.0 and 4.0, the lipoplexes mean size and PDI stabilize, 
probably because at these two charge ratios (+/-), most of the DNA is complexed.   
 Comparing the DNA/DODAB:MO (2:1) and DNA/DODAC:MO (2:1) lipolplexes , 
it seems that the exchange of bromide to chloride influences isoeletric point. In 
DNA/DODAC:MO (2:1) complexes, this increase occurs at a lower charge ratio (+/-). 
Also, at charge ratios (+/-) 3.0 and 4.0, the DNA/DODAC:MO (2:1) lipoplexes  appear to 
be smaller, so the exchange of Bromide to Chloride seems to lead to the formation of 
smaller complexes. This behavior may be associated either the size/charge or fluidty of 
the liposomes. 
The inclusion of DC-Chol in the liposomal formulation does not appear to exert 
great changes in terms of lipoplex mean size. When comparing DNA/DODAC:MO and 
DNA/DODAC:MO:DC-Chol lipoplexes, at charge ratios (+/-) 3.0 and 4.0, mean size 
ranges from 126 to 177 nm at charge ratio (+/-) 3.0 and from 118 to 193 nm at charge 
ratio (+/-) 4.0.  As to the DNA/DODAC:MO:DC-Chol complexes, it seems that the higher 
the MO content, the lower is the charge ratio (+/-) at which this increase in size occurs. 
The formulation that seems to form smaller complexes is DODAC:MO:DC-Chol (5:4:1). 
This is also the formulation with the highest MO content. 
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1.3 Effect of NaCl in liposome and lipoplex mean size and PDI 
In order to verify the effect on mean size and PDI of liposomes and lipoplexes in 
the presence of salts, DODAB/C:MO (2:1) and DODAC:MO:DC-Chol liposomes prepared 
by film hydration followed by extrution and lipoplexes prepared with salmon sperm 
DNA and DODAB/C:MO (2:1) and DODAC;MO:DC-Chol (6:3:1, 5:4:1, 4:1:1) liposomes 
were exposed to different concentrations of NaCl. The mean size and PDI for all the 
formulations registered upon this exposure are shown in figures 18-20. 
 
1.3.1 Liposomes  
The exposure of the liposomes to different concentrations of NaCl seems to 
influence the mean size of the population. A slight decrease in the mean size of the 
liposomes can be observed when these are exposed to a gradual increase in NaCl 
concentration. This is observed for all formulations except for DODAB:MO (2:1), where 
the liposomes mean size decreases up to 10 mM of NaCl and then suffers a great 
increase when exposed to higher concentrations of NaCl (Figure 18 (A)). 
The inclusion of DC-Chol in DODAC:MO liposomes does not seem to affect the 
their mean size with increase concentration of salt. 
The differences found in the mean size behavior of DODAB/C:MO liposomes 
might be explained by the different counter-ion. Indeed, Lopes and colleagues (Lopes 
et al., 2008) have reported that ionic strength is one of the conditions that causes the 
vesicle size to vary. DODAB has Bromide as counter ion, and the hydration of 
DODAB:MO liposomes occurs differently according the amount of chloride present in 
solution. At some point there might even be counter ion exchange. Since chloride is 
the counterion found in DODAC, the presence of different amounts of chloride in 
solution has a milder effect on DODAC:MO liposomes.  
The PDI values remain relatively constant for all concentrations for all 
formulations except, again, for the DODAB:MO (2:1) vesicles. The PDI values for this 
formulation are higher than the PDI values observed for all the other formulations, 
even in the absence of the salt. Its value increases with the increase of NaCl 
concentration, at first only slightly, but then after 10 mM of NaCl, its increase is 
markedly higher (Figure 18 (B)).  
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Figure 18. Mean size (A) and polidispersity index (B) of DODAB/C:MO (2:1) and 
DODAC:MO:DC-Chol (6:3:1, 5:4:1 and 4:1:1) liposomes produced by film hidration followed by 
extrusion and incubated with different concentrations of NaCl. B:M (2:1) – DODAB:MO 
liposomes with 2:1 ratio; C:M (2:1) – DODAC:MO liposomes with 2:1 ratio; C:M:D (6:3:1) – 
DODAC:MO:DC-Chol liposomes with 6:3:1 ratio; C:M:D (5:4:1) – DODAC:MO:DC-Chol 
liposomes with 5:4:1 ratio; C:M:D (4:1:1) – DODAC:MO:DC-Chol liposomes with 4:1:1 ratio. 
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1.3.2  Lipoplexes 
Figure 19 shows the effect of increasing concentarions of sal in the mean size 
when the lipoplexes at CR (+/-) 4.0 are exposed to increasing concentrations of salt. 
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Figure 19. Mean size (A) and polidisperdity index (B) of DNA/DODAB/C:MO (2:1) and 
DNA/DODAC:MO:DC-Chol (6:3:1, 5:4:1 and 4:1:1) lipoplexes at charge ratio (+/-) 4.0 incubated 
with different concentrations of NaCl. DNA/B:M (2:1) – DNA/DODAB:MO (2:1) lipoplexes; 
DNA/C:M (2:1) – DODAC:MO (2:1) lipoplexes; DNA/C:M:D (6:3:1) – DNA/DODAC:MO:DC-Chol 
(6:3:1) lipoplexes; DNA/C:M:D (5:4:1) – DNA/DODAC:MO:DC-Chol (5:4:1) lipoplexes; 
DNA/C:M:D (4:1:1) – DNA/DODAC:MO:DC-Chol (4:1:1) lipoplexes. 
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When the lipoplexes at this charge ratio (+/-) are exposed to increasing 
concentrations of salt, the mean size of the complexes seems to increase as well, even 
if it is only slightly for the DNA/DODAC:MO (2:1) and DNA/DODAC:MO:DC-Chol (6:3:1, 
5:4:1 and 4:1:1) lipoplexes. The DNA/DODAB:MO (2:1) complexes seem to have a slight 
increase in the mean size until the NaCl concentration of 10mM is reached. For NaCl 
concentrations of 50, 100 and 150 mM, the mean size of the complexes suffers a great 
increase (figure 19 (A)). The same can be verified on the PDI of the lipoplexes. The PDI 
values of the DNA/DODAC:MO (2:1) and DNA/DODAC:MO:DC-Chol (6:3:1; 5:4:1 and 
4:1:1) lipoplexes doesn’t suffer significant changes. However, just like the mean size, 
the PDI of DNA/DODAB:MO (2:1) complexes increases when the NaCl concentration is 
increased and it can be observed that the highest PDI values registered at charge ratio 
(+/-) 4.0 belong to DNA/DODAB:MO (2:1) complexes (figure 19 (B)).  
When comparing DNA/DODAB:MO and DNA/DODAC:MO lipoplexes, 
DNA/DODAC:MO lipoplexes seem to be more resistant to changes in mean size when 
incubated in NaCl. Again, this might be explained by the role played by the conterion in 
the liposomes used to produce the lipoplexes.  
The inclusion of DC-Chol in the liposomal formulation seems to have little effect 
on the mean size alteration of the lipoplexes produced with these liposomes. 
These same measurements were performed in the same conditions to 
lipoplexes of charge ratio (+/-) 3.0 (data not shown). The lipoplexes prepared at the 
charge ratio (+/-) 4.0, seem to be more resistant to the increase of salt. This behavior 
may be due to the fact that at this charge ratio the most DNA is complexed.  
The DNA/DODAC:MO lipoplexes at charge ratio (+/-) 4.0, lipoplexes are 
resistant to the presence of NaCl than DNA/DODAB:MO. Since chloride is present in 
solution, the DNA/DODAC based lipoplexes don’t suffer great perturbation in terms of 
mean size given that chloride is the counter ion present in DODAC. On the other hand, 
DODAB has a different counter ion, so the differences in mean size are more 
noticeable. 
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1.4 Effect of Serum in liposome and lipoplex mean size and PDI 
Interaction of serum components is bound to have an effect in the size of 
particles. This might influence the way the particles interact with the cellular 
membrane as well as the uptake pathway through which they enter the cell. 
Measuring particle size, it could be concluded that different amounts of serum will 
have different effects on particle size and PDI as well.  
In the absence of serum (figure 20), the liposomes present a narrow 
distribution, as it is to be expected of extruded vesicles. Since they form a 
homogeneous solution, the PDI value is below 0.1, and this is valid for all formulations. 
As to the lipoplexes, they presented a mean size distribution which ranged from 
approximately 140nm to 196nm and the PDI from 0.098 to 0.261 and only one 
population was detected. The formulations that presented the lowest values of PDI 
were also the ones with a smaller mean size.  
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Figure 20. Mean size (A) and polidispersity index (B) of DODA(X):MO (2:1) and DODAC:MO:DC-
Chol liposomes (6:3:1, 5:4:1 and 4:1:1) and DNA/DODA(X):MO (2:1) and DNA/DODAC:MO:DC-
Chol (6:3:1, 5:4:1 and 4:1:1) lipoplexes at charge ratio (+/-) 4.0 in the absence of serum. B:M 
(2:1) – DODAB:MO liposomes with 2:1 ratio; C:M (2:1) – DODAC:MO liposomes with 2:1 ratio; 
C:M:D (6:3:1) – DODAC:MO:DC-Chol liposomes with 6:3:1 ratio; C:M:D (5:4:1) – 
DODAC:MO:DC-Chol liposomes with 5:4:1 ratio; C:M:D (4:1:1) – DODAC:MO:DC-Chol 
liposomes with 4:1:1 ratio. 
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1.4.1 Liposomes  
In figure 21 and 22 the effects on the mean size and PDI of DODAB/C:MO and 
DODAC:MO:DC-Chol liposomes exposed to 30 and 80% of bovine serum.  
 
 
Figure 21. Mean size and polidispersity index (PDI) of DODAB/C:MO (2:1) and DODAC:MO:DC-
CHOL (6:3:1, 5:4:1 and 4:1:1) liposomes incubated with 30% bovine serum for 24h. B:M (2:1) – 
DODAB:MO liposomes with 2:1 ratio; C:M (2:1) – DODAC:MO liposomes with 2:1 ratio; C:M:D 
(6:3:1) – DODAC:MO:DC-Chol liposomes with 6:3:1 ratio; C:M:D (5:4:1) – DODAC:MO:DC-Chol 
liposomes with 5:4:1 ratio; C:M:D (4:1:1) – DODAC:MO:DC-Chol liposomes with 4:1:1 ratio. 
 
 
Figure 22. Mean size and polidispersity index (PDI) of DODAB/C:MO (2:1) and DODAC:MO:DC-
CHOL (6:3:1, 5:4:1 and 4:1:1) liposomes incubated with 80% bovine serum for 24h. B:M (2:1) – 
DODAB:MO liposomes with 2:1 ratio; C:M (2:1) – DODAC:MO liposomes with 2:1 ratio; C:M:D 
(6:3:1) – DODAC:MO:DC-Chol liposomes with 6:3:1 ratio; C:M:D (5:4:1) – DODAC:MO:DC-Chol 
liposomes with 5:4:1 ratio; C:M:D (4:1:1) – DODAC:MO:DC-Chol liposomes with 4:1:1 ratio. 
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The incubation of liposomes in 30% serum resulted in a slight decrease in the 
mean size at the timepoint 0h (the measurement was performed right after the 
particles incubation with serum) but as time passed, the mean size value of DODAC 
based liposomes increased. For DODAB:MO (2:1) liposomes the results were quite the 
opposite. These liposomes suffered a slight increase at time point 0h, when compared 
to the measurements performed in the absence of serum, but their mean size 
decreased after 6h. In 80% of serum, the effect in mean size appears to be the same 
for all formulations, although the increase in mean size is higher, especially after 24h 
of incubation. Moreover PDI values increase for both DODAB/C:MO and 
DODAC:MO:DC-Chol liposomes, but remains more or less constant throughout time. 
For liposomes incubated with 30% serum PDI rises to values above 0.5 but for 
liposomes incubated with 80% serum this increase in PDI is higher, reaching values of 
1.0.  
DODAB:MO (2:1) liposomes appear to be more resistant to the effect of serum 
than DODAC:MO (2:1) liposomes. The inclusion of DC-Chol in the formulation appears 
not to influence the resistance of DODAC:MO based liposomes.  
 
1.4.2 Lipoplexes 
The effect of serum on lipoplexes was tested by incubation of 
DNA/DODAB/C:MO and DNA/DODAC:MO:DC-Chol lipoplexes at charge ratio (+/-) 4.0 
in 30 and 80% of bovine serum. The results are displayed in figures 23 and 24. 
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Figure 23. Mean size and polidispersity index of DNA/DODAB/C:MO (2:1) and 
DNA/DODAC:MO:DC-Chol (6:3:1, 5:4:1 and 4:1:1) lipoplexes at charge ratios (+/-) 4.0 
incubated with 30% bovine serum for 24h. DNA/B:M (2:1) – DNA/DODAB:MO (2:1) lipoplexes; 
DNA/C:M (2:1) – DODAC:MO (2:1) lipoplexes; DNA/C:M:D (6:3:1) – DNA/DODAC:MO:DC-Chol 
(6:3:1) lipoplexes; DNA/C:M:D (5:4:1) – DNA/DODAC:MO:DC-Chol (5:4:1) lipoplexes; 
DNA/C:M:D (4:1:1) – DNA/DODAC:MO:DC-Chol (4:1:1) lipoplexes. 
 
 
 
 
Figure 24. Mean size and polidispersity index of DNA/DODAB/C:MO (2:1) and 
DNA/DODAC:MO:DC-Chol (6:3:1, 5:4:1 and 4:1:1) lipoplexes at charge ratios (+/-) 4.0 
incubated with 80% bovine serum for 24h. DNA/B:M (2:1) – DNA/DODAB:MO (2:1) lipoplexes; 
DNA/C:M (2:1) – DODAC:MO (2:1) lipoplexes; DNA/C:M:D (6:3:1) – DNA/DODAC:MO:DC-Chol 
(6:3:1) lipoplexes; DNA/C:M:D (5:4:1) – DNA/DODAC:MO:DC-Chol (5:4:1) lipoplexes; 
DNA/C:M:D (4:1:1) – DNA/DODAC:MO:DC-Chol (4:1:1) lipoplexes. 
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In figure 23, it is visible that DNA/DODAB:MO lipoplexes at CR(+/-) 4 look very 
stable in 30% serum during 24h. On the other hand, DNA/DODAC:MO lipoplexes 
display a feeble increase in mean size for the first 6h and then suffer a huge increase 
after 24h. These results appear to go along with the results obtained for 
DNA/DODAC:MO:DC-Chol lipoplexes. PDI values are also higher than the values 
registered for the lipoplexes in the absence of serum for all the tested formulations. 
The DODAB:MO liposomes seem to manifest relatively constant values of PDI along the 
24h. DODAC:MO liposomes maintain roughly the same values of PDI for the first 6h 
and then suffer an increment at 24h.  The DODAC:MO:DC-Chol liposomes PDI values go 
along with the values obtained for DODAC:MO liposomes for the first 3h. After 6h the 
values seem to rise and then lower again at 24h relatively to the values registered for 
DNA/DODAC:MO liposomes.  
When incubated with 80 % of serum, the DNA/DODAB:MO (2:1) lipoplexes 
appear to maintain a constant mean size for 24h. DNA/DODAC:MO (2:1) and 
DNA/DODAC:MO:DC-Col lipoplexes seem to display an increase the mean size 
although the DODAC:MO:DC-Chol 5:4:1 and 4:1:1 size increment is less than the one 
displayed for DODAC:MO:DC-Chol 6:3:1 formulation (Figure 24). Furthermore the 
mean size reached by the lipoplexes incubated with 80% serum was not as high as the 
mean size reached when incubated with 30% serum.  The PDI also suffered a great 
increase, reaching the value of 1 right after the incubation, except for the 
DNA/DODAC:MO:DC-Chol (5:4:1) formulation that only displayed this PDI value after 
24h. 
 The results for lipoplexes at charge ratio (+/-) 4.0 are in accordance with the 
results for lipoplexes of charge ratio (+/-) 3.0. (data not shown).  
It can be observed that the mean size and PDI of DNA/DODAB:MO (2:1) 
lipoplexes are more resistance to serum compared with the DNA/DODAC:MO (2:1) 
lipoplexes. 
Serum is composed of many proteins with smaller sizes and this influences the 
mean size. Actually, the measurements of the particles incubated with serum recorded 
the presence of three populations and the main population presents higher values of 
size when compared to the values registered in the absence of serum (see Appendix 
3). This might be due to the aggregation of smaller components of serum around the 
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liposomes and lipoplexes. Also, the percentage of particles of the main population 
decreases throughout time as the percentage of smaller populations increases (see 
Appendix 3). These smaller particles also increase in size as time goes by, which leads 
again to the possibility of particle aggregation, both around liposomes and lipoplexes 
and also between serum components and it is an effect observed for all liposomal 
formulations.  This might explain the lower values of mean size for lipoplexes 
incubated with 80% of serum, since the percentage of smaller particles that compose 
bovine serum is larger.  
It is interesting to note that DNA/DODAB/C:MO lipoplexes seem to be affect 
differently by serum components in terms of mean size. The different counter-ion 
appears to play a role in this. Also, DNA/DODAC:MO:DC-Chol lipoplexes show 
comparable results in terms of mean size alteration comparable to the ones observed 
in DNA/DODAC:MO lipoplexes in the first 6h. After 24h of incubation, 
DNA/DODAC:MO:DC-Chol liposomes have an higher increase in size relatively to 
DNA/DODAC:MO liposomes. 
The aggregation promoted by serum might be due to negatively charged serum 
proteins interacting with positively charged lipoplexes, coating their surface. Another 
possibility is the formation of “protein corona” in proteins resulting from the 
competition for the cationic membrane surface, which may force lipid vesicles to 
aggregate as a consequence of intermembrane repulsive barrier reduction (Yang et al., 
2012). 
It is usually observed low transfection efficiency in medium containing serum, 
partially due to the possibility of lipoplex instability caused by serum components. It 
has been reported in literature that the inclusion of cholesterol or cholesterol 
derivates, such as DC-Chol, into the liposomal formulation, reduces permeability to 
solutes and increases the packing parameter of phospholipids and that this increase 
can help to preserve liposomal stability in serum. Experiments performed with DC-
Chol-DOPE liposomes and DNA/DC-Chol-DOPE lipoplexes showed that there was an 
increase in transfection efficiency in the presence of serum (Caracciolo et al., 2010). 
Both liposomes and lipoplexes presented an increase in size when incubated in 50% of 
serum.  The authors suggested that the surface adsorption of protein corona results in 
a switch on the entry pathway into the cell. Instead of entering through a clathrin-
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dependent pathway, the lipoplexes should enter through caveolae-mediated 
mechanisms (Caracciolo et al., 2010). Indeed, the inclution of DC-Chol into the 
liposomal formulation seemed to result in better transfection efficiency, as it will be 
discussed later in this study. However, further studies are needed to comprehend 
serum interaction with lipoplexes and how that affects transfection efficiency. 
 
2. ζ -potencial assays 
2.1 ζ -potencial of liposomes 
The ζ –potencial of liposomes seems to vary according to the liposomal 
formulation and with the method of liposomal preparation, as it can be seen on figure 
25. For DODAB based liposomes, the values of zeta potencial obtained for the 
extruded liposomes don’t seem to vary significantly with the inclusion of DC-Chol in 
the formulation. However, for liposomes produced by ethanolic injection, the 
DODAB:MO:DC-Chol (6:3:1) presents a lower value of ζ –potencial when compared 
with the other DODAB based liposomes. 
DODAC based liposomes obtained by ethanolic injection seem to display an 
increase in the ζ –potencial values with the inclusion of DC-Cholesterol. On the other 
hand, extruded vesicles seem to exhibit an opposite behavior. DODAC:MO:DC-Chol 
extruded vesicles present slightly lower values of ζ –potencial when compared to 
DODAC:MO (2:1) vesicles. 
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Figure 25. ζ-potential of: (A) DODAB:MO (2:1) and DODAB:MO:DC-CHOL  (6:3:1, 5:4:1 and 
4:1:1) liposomes produced by ethanolic injection and by film hydration followed by extrusion; 
(B) DODAC:MO (2:1) and DODAC:MO:DC-CHOL  (6:3:1, 5:4:1 and 4:1:1) liposomes produced by 
ethanolic injection and by film hydration followed by extrusion. B:M (2:1) – DODAB:MO 
liposomes with 2:1 ratio; C:M (2:1) – DODAC:MO liposomes with 2:1 ratio; B:M:D (6:3:1) – 
DODAB:MO:DC-Chol liposomes with 6:3:1 ratio; C:M:D (6:3:1) – DODAC:MO:DC-Chol 
liposomes with 6:3:1 ratio; B:M:D (5:4:1) – DODAB:MO:DC-Chol liposomes with 5:4:1 ratio; 
C:M:D (5:4:1) – DODAC:MO:DC-Chol liposomes with 5:4:1 ratio; B:M:D (4:1:1) – 
DODAB:MO:DC-Chol liposomes with 4:1:1 ratio; C:M:D (4:1:1) – DODAC:MO:DC-Chol 
liposomes with 4:1:1 ratio. 
 
 
This might be a consequence of the method of liposome preparation, since 
ethanolic injection liposomes are very hard to be reproduced and parameters like 
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liposome size cannot be controlled. The size of the particles might be one parameter 
that explains the observed differences. 
 
2.2 ζ-potencial of lipoplexes 
The ζ-potencial of DNA/DODAB/C:MO (2:1) and DNA/DODAC:MO:DC-Chol 
lipoplexes prepared at different charge ratios was measured. The results are 
represented in figure 26. 
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Figure 26. ζ-potencial: (A) DNA/DODAB/C:MO (2:1) lipoplexes; (B) DNA/DODAC:MO (2:1) and 
DNA/DODAC:MO:DC-Chol (6:3:1, 5:4:1 and 4:1:1) lipoplexes at different charge ratios (+/-). 
DNA/B:M (2:1) – DNA/DODAB:MO (2:1) lipoplexes; DNA/C:M (2:1) – DODAC:MO (2:1) 
lipoplexes; DNA/C:M:D (6:3:1) – DNA/DODAC:MO:DC-Chol (6:3:1) lipoplexes; DNA/C:M:D 
(5:4:1) – DNA/DODAC:MO:DC-Chol (5:4:1) lipoplexes; DNA/C:M:D (4:1:1) – 
DNA/DODAC:MO:DC-Chol (4:1:1) lipoplexes. 
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Pure cationic liposomes exhibit a positive ζ- potential 43-60mV, depending on 
the lipid formulation. The formulation that presents the highest value is 
DODAC:MO:DC-Chol (5:4:1) and the one that presents the lowest value is DODAC:MO 
(2:1). Pure DNA presents negative ζ- potential values (data not shown). At lower 
charge ratios (+/-) like 0.5, the ζ- potential of the complexes is negative for all 
formulations. As the charge ratio (+/-) increases, the ζ- potential also increases until it 
reaches an isoelectric point. The charge ratio (+/-) at which the isoelectric point is 
reached differs according to the formulation and coincides with the great increase in 
mean size and PDI of the complexes mentioned previously in this study. After the 
neutralization point, the ζ- potential keeps increasing until charge ratio (+/-) 2.0 where 
it stabilizes and suffers only a slight increase in charge ratios (+/-) 3.0 and 4.0.  At 
charge ratio (+/-) 4.0 the value associated with the ζ- potential is around 20-26 mV 
(Figure 26). The DNA/DODAC:MO (2:1) lipoplexes seem to reach the isoelectric point at 
a lower charge ratio (+/-) the DNA/DODAB:MO (2:1) lipoplexes. As to the 
DNA/DODAC:MO:DC-Chol lipoplexes, the higher amount of MO associated with DC-
Chol in the formulation (5:4:1) seems to help in DNA complexation, since it reaches the 
isoelectric point at the lowest charge ratio(+/-) when compared with all the other 
formulations. This suggests that the complexation is different and dependent of the 
liposomal formulation, which also suggests structural variations between different 
formulations. 
 
2.3 Effect of NaCl in liposome and lipoplex ζ-potencial 
The ζ-potential of liposomes varies with each formulation in the absence of 
NaCl as previously stated. Previously in this study, the effects of NaCl in the mean size 
and PDI were assessed. In order to assess the effect of NaCl in the particles ζ-potential 
measurements of DODAB/C:MO and DODAC:MO:DC-Chol liposomes and 
DNA/DODAB/C:MO:DC-Chol and DNA/DODAC:MO:DC-Chol lipoplexes ζ-potential 
incubated with NaCl were performed.  
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2.3.1 Liposomes 
Figure 27 shows that upon increasing NaCl concentration up to 10 mM, the ζ-
potential suffers a slight increase except for the formulation (4:1:1), which suffers a 
slight decrease. At 10mM, the formulation (4:1:1) reaches a plateau, while the other 
formulations present a decrease in ζ-potential with the increase of NaCl concentration 
up to 150mM of NaCl. The observed values of ζ-potential at 150mM are lower the 
registered values of ζ-potential in the absence of NaCl. DODAC:MO (2:1) liposomes 
display lower values of ζ-potential than DODAB:MO (2:1) liposomes up to NaCl 
concentration of 10 mM. With increasing concentration of NaCl the opposite effect is 
observed. DODAC:MO:DC-Chol 6:3:1 and 5:4:1 formulations present slightly higher 
values than DODAC:MO (2:1). The DODAC:MO:DC-Chol (4:1:1) liposomes seem to be 
the exception. 
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Figure 27. ζ-potencial of DODAB/C:MO (2:1) and DODAB/C:MO:DC-CHOL  (6:3:1, 5:4:1 and 
4:1:1) liposomes produced by ethanolic injection and incubated with different concentrations 
of NaCl. B:M (2:1) – DODAB:MO liposomes with 2:1 ratio; C:M (2:1) – DODAC:MO liposomes 
with 2:1 ratio; C:M:D (6:3:1) – DODAC:MO:DC-Chol liposomes with 6:3:1 ratio; C:M:D (5:4:1) – 
DODAC:MO:DC-Chol liposomes with 5:4:1 ratio; C:M:D (4:1:1) – DODAC:MO:DC-Chol 
liposomes with 4:1:1 ratio. 
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2.3.2 Lipoplexes  
The effects on the ζ-potential of lipoplexes of charge ratio (+/-) 4.0 incubated 
with NaCl at different concentrations is represented in figure 28.  
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Figure 28. ζ-potencial of DNA/DODAB/C:MO (2:1), DNA/DODAC:MO (2:1) and 
DNA/DODAC:MO:DC-Chol (6:3:1, 5:4:1 and 4:1:1) lipoplexes at charge ratio (+/-) 4.0 incubated 
with different concentrations of NaCl. DNA/B:M (2:1) – DNA/DODAB:MO (2:1) lipoplexes; 
DNA/C:M (2:1) – DODAC:MO (2:1) lipoplexes; DNA/C:M:D (6:3:1) – DNA/DODAC:MO:DC-Chol 
(6:3:1) lipoplexes; DNA/C:M:D (5:4:1) – DNA/DODAC:MO:DC-Chol (5:4:1) lipoplexes; 
DNA/C:M:D (4:1:1) – DNA/DODAC:MO:DC-Chol (4:1:1) lipoplexes. 
 
 
 
The ζ-potential increases until a concentration of 10mM of NaCl is reached and 
there it presents its higher value. It then starts to decrease as the NaCl increases. At 
150 mM, the maximum concentration of NaCl tested, the ζ-potential of the lipoplexes 
is still higher than the ζ-potential of the lipoplexes in the absence of NaCl. The ζ-
potential of lipoplexes seems to display the same tendency on both charge ratios (+/-) 
3.0 and 4.0 (data not shown). 
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3. Fluorescence Ressonant Energy Transfer (FRET) assays 
The Fluorescence Resonance Energy Transfer (FRET) was used to monitor the 
complexation process of DNA. BOBO-1 was used to labeled  DNA acting as a donor and 
rho-PE used  to labeled liposomes acting as acceptor. This energy transfer was 
monitored for DNA/DODA(X):MO (2:1) and DNA/DODAC:MO:DC-Chol (6:3:1, 5:4:1, 
4:1:1) lipoplexes. It was observed a  decrease in the fluorescence emission of BOBO-1 
and the corresponding increase of fluorescence emission of rho-PE, indicating that an 
energy  transfer  between the two probes occurs as the charge ratio (+/-) increases.  
Figure 29 e Figure 30 presents the specral behavior for DNA:DODAB:MO and 
DNA:DODAC:MO ). 
 
 
 
Figure 29. Fluorescence emission spectra of BOBO-1 and rho-PE for DNA/DODAB:MO (2:1) 
lipoplexes at different charge ratios (+/-). 
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Figure 30. Fluorescence emission spectra of BOBO-1 and rho-PE for DNA/DODAC:MO (2:1) 
(lipoplexes at different charge ratios (+/-). 
 
 
 
Figure 31. FRET efficiency of DNA/DODAB/:MO (2:1) at different charge ratios (+/-). DNA/B:M 
(2:1): DNA/DODAB:MO (2:1) lipoplexes; DNA/C:M (2:1): DNA/DODAC:MO (2:1). 
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Figure 32. FRET efficiency of DNA/DODAC:MO (2:1) and DNA/DODAC:MO:DC-Chol (ratios 
6:3:1, 5:4:1, 4:1:1) at different charge ratios (+/-). DNA/C:M (2:1): DNA/DODAC:MO (2:1) 
lipoplexes; DNA/C:M:D (6:3:1): DNA/DODAC:MO:DC-Chol (6:3:1) lipoplexes; DNA/C:M:D 
(5:4:1): DNA/DODAC:MO:DC-Chol (5:4:1) lipoplexes; DNA/C:M:D (4:1:1): DNA/DODAC:MO:DC-
Chol (4:1:1) lipoplexes. 
 
 
In figures 31 and 32, it can be observed the efficiency of FRET (ФFRET), which 
reflects the complexation efficiency of the lipoplexes at different charge ratios (+/-). 
The efficiency increases until a certain charge ratio (+/-) where it reaches a plateau. 
The DODAC:MO (2:1) lipoplexes reach a plateau at charge ratio (+/-) 1.5 and 
DODAB:MO (2:1) lipoplexes reach a plateau at charge ratio (+/-) 2.0. DODAC:MO:DC-
Chol (5:4:1 and 4:1:1) lipoplexes reach a plateau at the same charge ratio (+/-) as 
DODAC:MO (2:1) lipoplexes but DODAC:MO:DC-Chol (6:3:1) lipoplexes reach it at 
charge ratio (+/-) 2.0. These results come in line with the results obtained from DLS 
and ζ-potential previously reported. The formulations which reach the plateau at 
charge ratio (+/-) 1.5 are also the formulations that reached the isoelectric point at 
lower charge ratios (+/-). At charge ratio (+/-) 4.0, the efficiency of FRET follows the 
order: C:M:C (5:4:1)> C:M (2:1)> C:M:C (6:3:1) > C:M:C (4:1:1) >B:M (2:1).  
It seem that chloride has a beneficial effect on DNA complexation on the 
DODAB/C:MO system as it can be observed when comparing the complexation 
efficiency of DODAB:MO (2:1) liposomes and DODAC:MO (2:1) liposomes. This might 
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be due to the size of the counter-ion chloride, which is smaller than Bromide and 
which might facilitate DNA complexation with liposomes. 
The inclusion of DC-Chol doesn’t seem to affect greatly the complexation 
efficiency of the system. It should be noted that the formulation which presents higher 
efficiency is DODAC:MO:DC-Chol (5:4:1). This is also the formulation with higher 
amount of MO. In previous studies with DODAB:MO vesicles, it was shown that there 
was a high dependence of the DNA complexation efficiency and lipoplex structure on 
the MO content. The fluidizing effect of MO is thought to be the reason for this high 
dependency since it favours lipid chains mobility (Neves Silva et al., 2008). 
 
4. Citotoxicity 
The citotoxicity induced by liposomes and lipoplexes was evaluated in two 
different cell lines. Murine fibroblasts, L929 cell line, were exposed for 48h to 
DODAB/C:MO (2:1) and DODAB/C:MO DC-Chol (ratios 6:3:1, 5:4:1 and 4:1:1) liposomes 
prepared by ethanolic injection or by film hydration method followed by extrusion. 
Human embryonic kidney cells (293T cell line) was also exposed to lipoplexes prepared 
by different liposomal formulations for 48h as well.  
MTT assay can be used to assess cell viability by acting as a marker of the cell 
metabolic capacity. Assessing the membrane integrity by LDH assay was also a method 
used to corroborate the results obtained by estimating cell viability through the 
metabolic capacity in MTT assays. Since only the Extracellular LDH was quantified, the 
enzymatic activity of this enzyme was calculated from the obtained values. The LDH 
enzyme is an intracellular enzyme that is released to the extracellular medium when 
the membrane integrity is compromised. 
 
4.1 DODAB/C:MO:DC-Chol liposomes 
Again, the counter ion exchange seems to somehow affect differently cell 
viability. In figure 33 it is possible to observe that the cell metabolism is more severely 
by DODAC liposomes compared to DODAB based liposomes. When exposed to a lipid 
concentration of 50 µg/mL, cell survival is practically null when in contact with 
liposomes produced by ethanolic injection or for liposomes produced by extrusion. At 
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a lipid concentration of 5 µg/mL, the liposomes produced by extrusion seem to be a 
little less toxic than the liposomes produce by ethanolic injection and this seems to be 
applicable to all formulations. Also, the inclusion of DC-Chol doesn’t seem to increase 
significantly the systems toxicity when compared to DODAC:MO (2:1) liposomes. In 
fact, the extruded liposomes with (5:4:1) and (4:1:1) formulations seem to be slightly 
less toxic than the DODAC:MO (2:1) liposomes (Figure 33).  
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Figure 33. Evaluation of the cytotoxicity (metabolic assay) in L929 cell line induced by induced 
by varying concentrations of DODAC:MO (2:1) and DODAC:MO:DC-Chol (6:3:1, 5:4:1, 4:1:1) 
prepared by ethanolic injection and film hydration followed by extrusion after 48h of 
incubation. Cells: cells alone; Cells: cells alone; DMSO: cells incubated with 30 % DMSO; H2O: 
cells incubated with the volume of H2O used to incubate de liposomes to a final concentration 
of 100 µg/mL. The mean (+/−) SD was obtained from two independent experiments.  
 
 
On the other hand, the DODAB based liposomes seem to be less toxic than the 
DODAC based liposomes, especially the liposomes produced by extrusion. At a lipid 
concentration of 50 µg/mL, the viability of cells exposed to liposomes prepared by 
ethanolic injection is practically null but the cells exposed to this same concentration 
of extruded liposomes seem to have a survival rate of 50% approximately for the 
DODAB:MO:DC-Chol liposomes and around 80% survival rate for DODAB:MO (2:1) 
liposomes (Figure 34).  
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Figure 34. Evaluation of the cytotoxicity (metabolic assay) in L929 cell line induced by induced 
by varying concentrations of DODAB:MO (2:1) and DODAB:MO:DC-Chol (6:3:1, 5:4:1, 4:1:1) 
prepared by ethanolic injection and film hydration followed by extrusion after 48h of 
incubation. Cells: cells alone; Cells: cells alone; DMSO: cells incubated with 30 % DMSO; H2O: 
cells incubated with the volume of H2O used to incubate de liposomes to a final concentration 
of 100 µg/mL. The mean (+/−) SD was obtained from two independent experiments.  
 
 
The liposomes prepared by ethanolic injection seem to be more toxic than the 
extruded vesicles, a fact that seems to be more noticeable for DODAB based 
liposomes. This might be related to the preparation system. Ethanol, the organic 
solvent used in liposome production might not be totally evaporated when in touch 
with the water. Also, the liposomes obtained by this method are more polydisperse 
and it is very difficult to reproduce the liposomes with identical sizes by this method 
since this feature cannot be as controlled as with extrusion, where membranes with a 
defined pore are used. 
Incubation with DODAC based liposomes seems to be associated with higher 
extracellular activity of the LDH enzyme, which reflects a higher number of cells with 
compromised membrane integrity. This is in agreement with the MTT results 
previously shown regarding DODAC based liposomes. Again, the inclusion of DC-Chol 
appears not to make a great difference in terms of cell viability when compared to 
DODAC:MO (Figure 35). 
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Figure 35. Evaluation of the cytotoxicity (cell membrane integrity) in L929 cell line induced by 
varying concentrations of DODAC:MO (2:1) and DODAC:MO:DC-Chol (6:3:1, 5:4:1, 4:1:1)  after 
48h of incubation.  Cells: cells alone; DMSO: cells incubated with 30 % DMSO; H2O: cells 
incubated with the volume of H2O used to incubate de liposomes to a final concentration of 
100 µg/mL. The mean (+/−) SD was obtained from two independent experiments.  
 
 
As to DODAB based liposomes, the extracellular LDH activity upon incubation 
with liposomes prepared by ethanolic injection is markedly higher at a lipid 
concentration of 100 µg/mL, which coincides with decreased cell viability registered in 
the MTT assays. However, the effect observed with the MTT assays regarding the 
addition of DC-Chol to the liposomal formulation is not so easily evident in the LDH 
assays. Furthermore, extracellular LDH enzyme activity in cells exposed to extruded 
liposomes at a concentration of 100 µg/mL is practically the same registered for 
exposure to lower concentrations of liposomes (Figure 36). This conflicts with the 
results obtained by the MTT assay, where cell viability decreases to almost 50% in cells 
exposed to DODAB:MO:DC-Chol extruded liposomes at a lipid concentration of 100 
µg/mL.  These discrepancies may be explained by the fact that the metabolism and 
membrane integrity are two different aspects concerning cell viability. 
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Figure 36. Evaluation of the cytotoxicity (cell membrane integrity) in L929  cell line induced by 
varying concentrations of DODAB:MO (2:1) and DODAB:MO:DC-Chol (6:3:1, 5:4:1, 4:1:1) 
prepared by ethanolic injection and film hydration followed by extrusion after 48h of 
incubation.  Cells: cells alone; DMSO: cells incubated with 30 % DMSO; H2O: cells incubated 
with the volume of H2O used to incubate de liposomes to a final concentration of 100 µg/mL. 
The mean (+/−) SD was obtained from two independent experiments.  
 
 
4.2 DNA/DODAB/C:MO:DC-Chol lipoplexes 
Lipoplexes may affect differently cell membrane structure, metabolism or cell 
proliferation.  The 293T cell line will be used to perform transfection assays so the 
citotoxicity induced by lipoplexes in L929 cell line was confirmed in 293T cell line. In 
fact, the results obtained for lipoplexes of charge ratio (+/-) 4.0 on cell viability show 
some differences when compared with the results obtained for liposomes. First of all, 
not all lipoplexes prepared with DODAB based liposomes promote higher cell viability 
has it was observe for DODAB liposomes earlier. In fact, lipoplexes prepared with 
DODAB:MO:DC-Chol with 6:3:1 and 4:1:1 ratios and produced by ethanolic injection, 
appear to be the most harmfull for cell metabolism. Lipoplexes prepared with 
DODAB:MO with 2:1 ratio and produced by ethanolic injection also have a great effect 
in cell viability but not to the same extent. Yet, lipoplexes prepared with 
DODAB:MO:DC-Chol liposomes produced by ethanolic injection don’t have such a 
pronounced effect on cell survival (Figure 37).  
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As to the toxicity displayed by lipoplexes prepared with DODAC liposomes, the 
difference in cell viability between the two methods of liposome production don’t 
seem to be so pronounced as in DODAB based liposomes. It is important to state that 
lipid concentration varies a little according to the amount of cationic lipids included in 
the liposomal formulation, in order to obtain lipoplexes of charge ratio (+/-) 4.0, since 
the amount of pDNA used in the lipoplex production is constant. 
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Figure 37. Evaluation of the cytotoxicity (metabolic assay) in 293T cell line induced by 
lipoplexes of pDNA/DODA(X):MO (2:1) and pDNA/DODA(X):MO:DC-Chol (6:3:1, 5:4:1, 4:1:1), 
based on liposomes produced by ethanolic injection and film hydration followed by extrusion, 
at charge ratio (+/-) 4.0  after 48h of incubation.  pDNA: cells incubated with 1µg/µL of plasmid 
DNA; Cells: cells alone. B CR (+/-) 4.0: pDNA/DODAB:MO and pDNA/DODAB:MO:DC-Chol 
lipoplexes. C CR (+/-) 4.0: pDNA/DODAC:MO and pDNA/DODAC:MO:DC-Chol lipoplexes. The 
mean (+/−) SD was obtained from two independent experiments.  
 
 
LDH enzyme activity is higher when cells contact with lipoplexes prepared with 
DODAB:MO:DC-Chol with 6:3:1 and 4:1:1 ratios and DODAB:MO 2:1 ratio and 
produced by ethanolic injection, indicating that these lipoplexes have a greater effect 
in cell membrane integrity and, therefore, greater effect in cell viability. These results 
are in accordance with the results obtained by MTT assay. Lipoplexes prepared with 
DODAC:MO:DC-Chol 6:3:1 and 5:4:1 and produced by both methods appear to cause 
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reduction of LDH enzyme activity and therefore, have less impact in cell viability 
(Figure 38).  
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Figure 38. Evaluation of the cytotoxicity (cell membrane integrity) in 293T cell line induced by 
lipoplexes of pDNA/DODA(X):MO (2:1) and pDNA/DODA(X):MO:DC-Chol (6:3:1, 5:4:1, 4:1:1), 
based on liposomes produced by ethanolic injection and film hydration followed by extrusion, 
at charge ratio (+/-) 4.0  after 48h of incubation.  DMSO: cells incubated with 30 % DMSO; 
Cells: cells alone. pDNA: cells incubated with 1µg/µL of plasmid DNA; Cells: cells alone. B CR 
(+/-) 4.0: pDNA/DODAB:MO and pDNA/DODAB:MO:DC-Chol lipoplexes. C CR (+/-) 4.0: 
pDNA/DODAC:MO and pDNA/DODAC:MO:DC-Chol lipoplexes. The mean (+/−) SD was obtained 
from two independent experiments.  
 
 
It seems that for DODAC based lipossomes and lipoplexes, the DODAC:MO:DC-
Chol  (5:4:1) formulation is less toxic, especially the extruded liposomes and lipoplexes 
produced with these. In DODAC based liposomes, this formulation is the one with 
greater amount of MO (XMO₌0.4). Previous work with DODAB:MO system showed that 
higher content of MO reduced the citotoxicity levels in more than one cell line (Neves 
Silva et al., 2012), in both liposomes and lipoplexes, which agrees with the results of 
this work, even with the inclusion of DC-Chol (XDC-Chol₌0.1) in the (5:4:1) formulation. 
Furthermore, the reduction of MO content (XMO≈0.16) and inclusion of higher content 
of DC-Chol (XDC-Chol ≈0.16) in the liposomal formulation (4:1:1) causes toxicity values 
comparable to the DODAC:MO (2:1) liposomes. Indeed, in previous reports, it was 
observed in some cell lines that DC-Chol induced reduced toxicity when compared with 
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commercial reagent Lipofectamine (Gao and Huang, 1991). The levels of toxicity seem 
to be a little higher only with liposomes and lipoplexes prepared with DODAC:MO:DC-
Chol (4:1:1) produced by ethanolic injection. This might be explained, as mentioned 
before, by the preparation method itself, since the produced vesicles have different 
structures and variable size. Moreover, the presence of ethanol in the solution might 
be an issue since the evaporation of the organic solvent when injecting the lipids into 
the aqueous solution might not be complete. 
DODAB based liposomes and lipoplexes seem to cause less toxicity than the 
DODAC based liposomes and lipoplexes. Also, the diference in toxicity induced by the 
two liposome preparation methods is greater than the one observed for DODAC based 
liposomes. The two counter ions, Bromide and Chloride, must influence differently 
parameters such as particle interaction with the cell membrane and pDNA compaction. 
It would be interesting to further explore this topic in future studies. 
 
5. Transfection 
Transfection efficiency was evaluated by the detection of β-galactosidase, the 
protein encoded in the pSV-β-gal plasmid. As reporter gene, β-galactosidase can be 
detected by a colorimetric assay. The transfection efficiency of pDNA/ DODAB/C:MO 
and pDNA/DODAB/C:MO:DC-Chol lipoplexes at charge ratio (+/-) 4.0, prepared with 
liposomes produced by ethanolic injection and film hydration method followed by 
extrused was evaluated and compared with that obtained with the commercial 
reagent EzWay. As illustrated in figure 39, DODAC based lipoplexes seem to present 
better results in terms of transfection efficiency than DODAB based lipoplexes. 
Furthermore, lipoplexes prepared with extruded DODAC liposomes also have 
enhanced tranfection efficiency when compared to the ones prepared with DODAC 
liposomes produced by ethanolic injection. However, in DODAB based lipoplexes, the 
effect seems to be quite the opposite. The lipoplexes prepared with ethanolic injection 
liposomes seem to yield better results. The results obtained with DODAC based 
lipoplexes are in the same order of magnitude as EzWay ™. The pDNA/DODAC:MO:DC-
Chol (4:1:1) lipoplexes was the formulation that promoted higher transfection 
efficiency, even higher than the commercial system, followed by (6:3:1) and (5:4:1) 
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formulations. In fact, the inclusion of DC-Chol in the liposomal formulations appears to 
result in improved transfection efficiency, since in DODAC based liposomes, the 
formulations containing DC-Chol showed better results when compared with 
DODAB:MO (2:1). Although the DODAB based system was associated with lower 
transfection efficiency, contrary to the DODAC system, ethanolic injection liposomes 
resulted in better transfection efficiency. The inclusion of DC-Chol also appears to 
improve transfection when comparing DODAB:MO (2:1) with DODAB:MO:DC-Chol.  
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Figure 39. Transfection efficiency of 293T cells by lipoplexes of pDNA/DODA(X):MO (2:1) and 
pDNA/DODA(X):MO:DC-Chol (6:3:1, 5:4:1, 4:1:1), based on liposomes produced by ethanolic 
injection and film hydration followed by extrusion, at charge ratio (+/-) 4.0 with 1.0 μg 
pDNA/well after 48h of incubation. Transfected pDNA encoded the β-galactosidase gene 
whose activity was evaluated by a colorimetric assay after 48 h of incubation. pDNA: cells 
incubated with free pDNA; EzWay: cells transfected using EzWay ™ as lipofection agent. The 
mean (+/−) SD was obtained from three independent experiments. 
 
 
In figure 40 is depicted the amount of B-galactosidas per amount of proteins in 
the transfected samples. The amount of proteins in the transfected samples was 
quantified by the Bradford method. This was done in order to normalize the 
transfection assay results for varying cell numbers which could result of citotoxicity, for 
example. The same tendency observed in the transfection results can be observed.  
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Figure 40. Quantification of B-gal miliunits in total protein content of 293T cells transfected 
with lipoplexes of pDNA/DODA(X):MO (2:1) and pDNA/DODA(X):MO:DC-Chol (6:3:1, 5:4:1, 
4:1:1), based on liposomes produced by ethanolic injection and film hydration followed by 
extrusion, at charge ratio (+/-) 4.0 with 1.0 μg pDNA/well after 48h of incubation. Protein 
quantification of transfected cells was performed by the Bradford method. pDNA: cells 
incubated with free pDNA; EzWay: cells transfected using EzWay ™ as lipofection agent. The 
mean (+/−) SD was obtained from three independent experiments. 
 
 
Comparing DODAB and DODAC based lipoplexes without the inclution of DC-
Chol, the transfection efficiency is in the same order of magnitude for lipoplexes 
prepared with extruded liposomes. However, the inclusion of DC-Chol has different 
effects on DODAB and DODAC based lipoplexes. When including DC-Chol in the 
liposomal formulation of DODAC bases lipoplexes, they improved transfection 
efficiency, which is not observed for DODAB based lipoplexes. The method of liposome 
preparation shows different results for DODAB and DODAC based liposomes, with or 
without the inclusion of DC-Chol. These different results might be explained with 
different phase transition behaviours in DODAB and DODAC, but further studies like 
Differential scanning calorimetry are needed to assess this hypothesis. 
Transfection experiments were also performed in L929 cells line in order to 
verify if the lipoplexes could transfect efficiently a different cell line. The experiment 
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was performed in the same conditions described for 293T cell line. The transfection 
efficiency of pDNA/DODA(X):MO and pDNA/DODA(X):MO:DC-Chol lipoplexes prepared 
with liposomes produced by ethanolic injection and film hydration method followed by 
extrused was evaluated and compared with that obtained with the commercial 
reagent EzWay ™ at charge ratio (+/-) 4.0. However, in these experiments, transfection 
efficiency was very poor, for both the commercial reagent and for the lipoplexes 
characterized in this study (data not shown). This shows that transfection efficiency 
not only depends on the liposomal formulation on which the lipoplexes are prepared 
but also on the cell type. This might be explained by the nature of the entry pathway of 
the lipoplexes into the cell according to the endocytic machinery (Rejman et al., 2005). 
The exchange of the counterion bromide for chloride arises as a beneficial trade in 
terms of tranfection efficiency. The differences that emerge with counterion exchange 
are also reflected in the inclusion of DC-Chol in the liposomal formulation. This 
inclusion appears to be more beneficial in DODAC based liposomes. However, further 
studies are required in order to understand why the liposome preparation methods of 
the liposomes used to prepare the lipoplexes affect in such different ways the 
transfection efficiency. It would be interesting to study how this difference is reflected 
in lipoplex structure, internalization and lipoplex destabilization.
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IV .Conclusion and Future perspectives 
 
This work was focused on developing and characterizing DODAB/C:MO:DC-Chol 
lipoplexes as new and effective non-viral vectors suitable to perform efficient 
transfection. 
In previous studies, DODAB:MO based lipoplexes showed promising results as 
non-viral vectors and the use of MO as helper lipid was proven successful (Neves Silva 
et al., 2012). Furthering these previous results by our research group, three major 
variables were studied in the present work: counter ion exchange, inclusion of DC-Chol 
in the liposomal formulation and liposome preparation methods.  
It was thought that the exchange of the counterion bromide in DODAB for 
chloride in DODAC would possible influence liposome properties, which was indeed 
verified in this study. DODAB:MO (2:1) liposomes presented a larger mean size 
compared to DODAC (2:1) liposomes, irrespective of being produced either by 
ethanolic injection or by film hydration followed by extrusion. The inclusion of DC-Chol 
in DODAC based liposomes produced by film hydration followed by extrusion, 
however, did not have a significant effect on their mean size.   
The ζ-potencial values of the liposomes seem to vary with the liposomes 
preparation method. DODAC based liposomes show higher ζ -potencial values for 
liposomes produced by ethanolic injection. For DODAB based liposomes, the same 
trend seems to occur, although the difference between the values displayed by the 
two methods is narrower.  
The counter ion exchange also influenced the pDNA complexation with the 
liposomes, as studied by FRET and DLS measurements. DODAC:MO (2:1) seemed to 
complex with pDNA at a lower charge ratio and the complexation efficiency of 
DODAC:MO (2:1) was higher. Also, the lipoplexes mean size of DNA/DODAC:MO (2:1) 
lipoplexes was slightly smaller than the mean size of DNA/DODAB:MO (2:1) lipoplexes. 
The complexation of DNA/DODAC:MO:DC-chol lipoplexes was in agreement with the 
results obtained for DNA/DODAC:MO (2:1), although DNA/DODAC:MO:DC-Chol (5:4:1) 
was the most efficient formulation in incorportating the plasmid DNA. The mean size 
and ζ-potencial measurements of the lipoplexes seem to corroborate this observation. 
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Furthermore, in the presence of higher concentrations of NaCl, DODAC:MO 
(2:1) liposomes produced by extrusion and DNA/DODAC:MO lipoplexes prepared with  
these liposomes seemed to be more stable than the DODAB:MO (2:1) liposomes and 
DNA/DODAB:MO (2:1) lipoplexes. The inclusion of DC-Chol in DODAC based liposomes 
and lipoplexes had hardly any influence in the particles stability. This is valid for both 
mean size and Z-potential of the particles. 
The exposure of DODAB/C:MO and DODAC:MO:DC-Chol liposomes to serum 
seems to be slightly more destabilizing to DODAC:MO (2:1) liposomes than to 
DODAC:MO (2:1) liposomes in terms of affecting their mean size. DC-Chol inclusion in 
DODAC based liposomes does not seem to cause significant effect when compared to 
DODAC:MO liposomes. The same trends seem to apply in lipoplex destabilization in the 
presence of serum. 
Regarding citotoxicity, DODAC based liposomes and lipoplexes seem to induce 
more toxicity than the DODAB based liposomes and lipoplexes. The liposome 
preparation method also modulates toxicity. This difference is more pronounced in 
DODAB based liposomes. DC-Chol appears to exert the same effect in cell toxicity 
when included in either DODAB or DODAC based liposomes and lipoplexes.  
Concerning transfection efficiency, the liposome preparation method used 
leads to different transfection results. DNA/DODAC:MO and DNA/DODAC:MO:DC-Chol 
lipoplexes produced by extruded liposomes yield better transfection results. However, 
in DNA/DODAB:MO and DNA/DODAC:MO:DC-chol lipoplexes, the opposite effect was 
registered. Again, the differences inherent to the preparation methods seem to be 
more noticeable in DODAB based lipoplexes. The addition of DC-Chol to the 
formulation seemed to have different effects in pDNA/DODAB:MO:DC-Chol  and 
pDNA/DODAC:MO:DC-Chol lipoplexes. pDNA/DODAC:MO:DC-Chol lipoplexes seem to 
have enhanced tranfection efficiency when compared to pDNA/DODAC:MO lipoplexes. 
For DODAB based lipoplexes, only pDNA/DODAB:MO:DC-Chol 4:1:1 and 5:4:1 
lipoplexes prepared with liposomes produced by ethanolic injection displayed better 
results than pDNA/DODAB:MO(2:1) liposomes. 
The differences displayed by DODAB and DODAC based lipoplexes still require 
further research. The different efficiency in transfection may be due to 
physicochemical characteristics such as differences in the fluidity of the system. 
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Therefore, techniques like DSC should be employed in order to confirm this 
hypothesis. Also, further optimization studies on the inclusion of DC-Chol in the 
liposomal formulations are needed.  
Interestingly, DODAC based lipoplexes, which yielded better transfection 
results, also seem to induce higher levels of citotoxicity. Moreover, 
DNA/DODAC:MO:DC-Chol 5:4:1 and 4:1:1 lipoplexes were the most efficient 
formulations in transfection. DNA/DODAC:MO:DC-Chol 4:1:1 lipoplexes displayed 
higher levels of toxicity and lower DNA complexation efficiency than the 
DNA/DODAC:MO:DC-Chol 5:4:1 lipoplexes. Also, the mean size of 4:1:1 lipoplexes 
seems to be slightly less stable in the presence of NaCl and serum. However, 
transfection efficiency levels are slightly higher in 4:1:1 lipoplexes. This might be due to 
differences on the lipoplexes interaction with the cell membrane. 
The morphology and structure of lipoplexes is an important aspect to consider 
when it comes to transfection efficiency because of the influence exerted by the 
chemical nature of the constituents and also because of the surrounding environment. 
Moreover, there are other aspects of great significance that determine the 
effectiveness of vector internalization and, eventually, successful transgene 
expression. Taking this into consideration, the structure of the lipoplexes is a 
fundamental aspect to study in the future, as well as the way this structure might be 
shaped in accordance to different proportions of the constituents and how this might 
influence lipoplex-cell interaction. Furthermore, internalization studies are also in 
order to unveil how the lipoplexes enter the cell. 
In the long term, DODAC:MO:DC-Chol lipoplexes appear as a new and 
promising non viral vector. 
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  Mean size (nm) PDI Pop. 1 % Pop. 2 % Pop. 3 % 
Ethanolic 
injection 
B:M:D (6:3:1) 214,5 ± 2,828 0,543 ± 
0,115 
312,9 ± 
25,31 
96,2 ± 
1,1 
4998 ± 
511,9 
3,8 ± 
1,1 
0 0 
B:M:D (5:4:1) 134,4 ± 1,115 0,263 ± 
0,003 
183,3 ± 
3,523 
100 0 0 0 0 
B:M:D (4:1:1) 122,5 ± 67,44 0,493 ± 
0,168 
108,6 ± 
22,58 
72,7 ± 
15,8 
1714 ± 
2718 
15,4 ± 
13,8  
5,172 ± 
6,563 
6,5 ± 1,2 
B:M (2:1) 269,6 ± 39,74 0,580 ± 
0,02 
246,4 ± 
13,08 
93,8 ± 
8,8 
2493 ± 
3525 
6,3 ± 
8,8 
0 0 
C:M:D (6:3:1) 95,57 ± 4,744  0,482 ± 
0,035 
157 ± 
13,99 
87,7 ± 
10,9 
1809 ± 
3096 
8,1 ± 
5,9 
2810 ± 
2574 
4,2  ± 5,6 
C:M:D (5:4:1) 97,76 ± 5,683 0,665 ± 
0,176 
214,8 ± 
137,1 
63,8 ± 
28,7 
1655  ± 
2496 
30,2 ± 
23,5 
10,31 ± 
9,119 
3,5 ± 3,2 
C:M:D(4:1:1) 108,9 ± 0,8485 0,426 ± 
0,012 
148,1 ± 
1,061 
90,8 ± 
3,5 
4450 ± 
273,7 
6,3 ± 
0,6 
12,03 ± 
17,01 
2,9 ± 4,1 
C:M (2:1) 73,66 ± 0,02828 0,535 ± 
0,002 
181,8 ± 
8,980 
67,8 ± 
0,4 
34,17 ± 
2,553 
29,7 ± 
0,3 
4881 ± 
152  
2,4 ± 0  
Film 
hydration 
followed 
by 
extrusion 
B:M:D (6:3:1) 135,4 ± 0,8505 0,125 ± 
0,015 
151,8 ± 
1,380 
100 0 0 0 0 
B:M:D (5:4:1) 131,2 ± 1,002 0,072 ± 
0,015 
142,9 ± 
1,069 
100 0 0 0 0 
B:M:D (4:1:1) 131,2 ± 0,6557  0,101 ± 
0,013 
147,3 ± 
2,401 
100 0 0 0 0 
B:M (2:1) 132,8 ± 0,9247 0,085 ± 
0,013 
145,3 ± 
2,614  
100 0 0 0 0 
C:M:D (6:3:1) 112,4 ± 1,419  0,087 ± 
0,004 
123,3 ± 
2,219 
100 0 0 0 0 
C:M:D (5:4:1) 125,7 ± 0,3 0,083 ± 
0,002 
137,8 ± 
0,4509 
100 0 0 0 0 
C:M:D(4:1:1) 106,8 ± 0,7095  0,077 ± 
0,016 
116,8 ± 
1,229 
100 0 0 0 0 
C:M (2:1) 109,5 ± 1,1 0,071 ± 
0,002 
119,2 ± 
1,422 
100 0 0 0 0 
Table 1. Size and PDI values of DODAB/C:MO and DODAB/C:MO:DC-Chol liposomes produced by ethanolic injection and film hydration followed by extrusion.
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DODAB/C:MO:DC-Chol liposomes
B:
M
 (2
:1
)
C:
M
 (2
:1
)
B:
M
:D
 (6
:3
:1
)
C:
M
:D
 (6
:3
:1
)
B:
M
:D
 (5
:4
:1
)
C:
M
:D
 (5
:4
:1
)
B:
M
:D
 (4
:1
:1
)
C:
M
:D
 (4
:1
:1
)
0.0
0.2
0.4
0.6
0.8
1.0
Ethanolic injection 0 weeks
Ethanolic injection 9 weeks
extrusion 0 weeks
extrusion 9 weeks
P
D
I
 
 
Comparison of the polidispersity index (PDI) of DODAB/C:MO (2:1) and DODAB/C:MO:DC-CHOL 
(6:3:1, 5:4:1 and 4:1:1) liposomes produced by ethanolic injection and by film hydration 
followed by extrusion over 9 weeks. B:M (2:1) – DODAB:MO liposomes with 2:1 ratio; C:M 
(2:1) – DODAC:MO liposomes with 2:1 ratio; B:M:D (6:3:1) – DODAB:MO:DC-Chol liposomes 
with 6:3:1 ratio; C:M:D (6:3:1) – DODAC:MO:DC-Chol liposomes with 6:3:1 ratio; B:M:D (5:4:1) 
– DODAB:MO:DC-Chol liposomes with 5:4:1 ratio; C:M:D (5:4:1) – DODAC:MO:DC-Chol 
liposomes with 5:4:1 ratio; B:M:D (4:1:1) – DODAB:MO:DC-Chol liposomes with 4:1:1 ratio; 
C:M:D (4:1:1) – DODAC:MO:DC-Chol liposomes with 4:1:1 ratio. 
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Table 2.  Size and PDI of DODAB:MO (2:1) liposomes and DNA/DODAB:MO (2:1) lipoplexes incubated with 30% and 80% serum at different time points for 24h. 
Time point  % serum Mean size PDI Pop. 1 % Pop. 2 % Pop. 3 % 
0h liposomes 0 135,4 ± 0,8083 0,077 ± 0,015 148,3 ± 3,56 100 0 0 0 0 
30 206,9 ± 5,147 0,578 ± 0,009 398,6 ± 14,3 93,1 ± 5,2 1675 ± 2816 6,2 ± 4,5 1651 ± 2860 0,6 ± 1,1 
 80 130,2 ± 5,187 1  640,7 ± 142,4 75,8 ± 3,6 40,5 ± 3,822 14,2 ± 0,9 1513 ± 2607 7,2 ± 0.5 
3h 30 140,5 ± 1,531 0,568 ± 0,008 257,9 ± 3,772 92,3 ± 1.1 28,18 ± 7,191 6,3 ± 1,3 2,465± 4,27 1,3 ±2,3 
80 51,99 ± 0,5415  1 372,4 ± 46,35 62,5 ± 0,9 35,63 ± 2,56 23,4 ± 2,4 7,458 ± 0,1197 12,8 ± 0,2 
6h 30 140,4 ± 1,607 0,563 ± 0,005 244,6 ± 4,508 90,4 ± 0,4 20,55 ± 3,065 5,9 ± 0,9 7,031 ± 0,8731 3,7 ± 0,8 
80 62,24 ± 0,5948 1 495,9 ± 39,96 63,1 ± 0,9 38,35 ± 1,498 22,3 ± 0,7 7,684 ± 0,1731 12,4 ± 0,6 
24h  30 138,5 ± 1,058 0,571 ± 0,005 256,1 ± 4,882 90,3 ± 2,7 20,14 ± 9,267 6,4 ± 0,3 19,93 ± 26.56 3,2 ± 2,8 
80 101,8 ± 1,457 1 654,3 ± 15,13 71,3 ± 0,7 43,31 ± 3,175 18,5 ± 1,7 7,595 ± 0,2474 9,2 ± 0,4 
0h lipoplexes C.R. (+/-) 4,0 0 175,7 ± 1,422 0,106 ± 0,014 199,2 ± 1,704 100 0 0 0 0 
30 149,9 ± 1,562 0,658 ± 0,008 309,4 ± 5,341 87,4 ± 3,3 42,54 ± 12,5 8,7 ± 0,3 6,161 ± 5,383 4 ± 3,5 
 80 64,85 ± 1,106 1 394,7 ± 15,41 70,6 ± 0,6 37,31 ± 3,635 19,3 ± 1,4 7,68 ± 0,4862 10,1 ± 1,2 
3h 30 166,8 ± 0,3055 0,608 ± 0,008 334,9 ± 8,929 90,6 ± 2,6 25,04 ± 6,664 7,8 ± 0,2 17,7 ± 30,65 0,8 ± 1,4 
80 96,91 ± 5,088 1 550,2 ± 14,19 72,4 ± 1,7 39,09 ± 5,652 16,2 ± 1,0 8,259 ± 0,9373 9,9 ± 1,2 
6h 30 166,9 ± 3,061 0,608 ± 0,008 327,5 ± 14,64 90,4 ± 2,8 32,65 ±9,515 7,8 ± 0,6 2,931 ± 5,077 1,9 ± 3,2 
80 74,72  ± 0,1501 1 494,2 ± 17,85 72,1 ± 0,3 35,47 ± 2,895 18,5 ± 1.0 7,189 ± 0,5048 9,4 ± 1,1 
24h  30 177,8 ± 1,721 0,62 ± 0,005 344,3 ± 2,417 92,5 ± 1,9 27,99 ± 6,645 6,4 ± 0,5 2,219 ± 3,843 1,1 ± 2,0 
80 101,9 ± 0,8 1 712,6 ± 88,57 71,9 ± 1,8 37,62 ± 4,144 16 ± 1,2 7,965 ± 0,5619 9,8 ± 1,0 
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Time point  % serum Mean size PDI Pop. 1 % Pop. 2 % Pop. 3 % 
0h liposomes 0 124,2±0,7234 0,095±0,018 137,9±1,389 100 0 0 0 0 
30 80,44±0,7113 0,602±0,002 183,3±4,822 81,8±2 27,62±7,418 11,9±1,6 7,469±0,4436 6,3±1,2 
 80 47,35±0,1457 1 336,4±5,437 63,2±5,3 39,01±9,238 24,4±3,4 7,746±0,5095 12,4±1,8 
3h 30 125,3±1,804 0,555±0,015 238,8±26,32 87,4±3,3 26,91±16,85 9,1±1.6 1684±2903 3,5±2,2 
80 54,54±2,874 1 636±109 60,5±3,4 36,51±5,385 25,7±2,4 7,525±0,5942 12,5±1,9 
6h 30 165,2±0,9849 0,555±0,004 303,3±18,88 94±5,3 15,93±17,94 3,8±3,3 1523±2632 2,2±2 
80 123,8±16,05 1 1717±660,6 65,2±2 33,13±1,783 18,4±2,7 65,82±101,2 10,5±0,8 
24h  30 214,8±3,387 0,567±0,043 340,3±96,64 77,3±15,5 1778±2249 19,2±18,8 1650±2828 2,4±2,5 
80 543,2±158,60 1 4557±573,7 58±17,5 31,05±3,004 17,3±6 52,17±77,71 11,1±3,3 
0h lipoplexes C.R. (+/-) 4,0 0 165,1±3,512 0,234±0,002 214,9±12,29 98,1±1,7 2505±2256 1,9±1,7 0 0 
30 104,2±0,3215 0,559±0,006 202,7±2,179 85,7±0,7 25,08±13,95 8,3±1,4 19,95±21,32 6±0,9 
 80 53±0,6122 1 277,5±11,45 69,4±1,5 33,96±1,571 20,2±1,3 7,267±0,3049 10,4±0,2 
3h 30 113,9±1,308 0,6±0,005 219,2±4,65 90,4±1,3 19,14±6,402 8,3±0,6 3,405±3,409 1,3±1,9 
80 116±9,872 1 860,2±78,43 60,3±4 44,03±3,124 21,2±1 1368±2356 10,7±0,5 
6h 30 202,2±2,663 0,553±0,018 397,7±25,06 95,6±3,8 30,99±26,92 4,4±3,8 0 0 
80 288,9±54,36 1 4275±564,1 50,7±13 34,93±4,667 20,2±3,8 636±591,6 15,2±6,5 
24h  30 1727±124 0,746±0,006 3779±484 80±11,4 704,6±366 17,8±8,5 61,57±106,6 2,2±3,8 
80 391,6±74,91 1 4227±514,3 67,3±7,6 44,13±28,41 11,8±2,2 29,03±25,7 9,8±0,8 
 Table 3. Size and PDI of DODAC:MO (2:1) liposomes and DNA/DODAC:MO (2:1) lipoplexes incubated with 30% and 80% serum at different time points at different time 
points for 24h.
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Time point  % serum Mean size PDI Pop. 1 % Pop. 2 % Pop. 3 % 
0h liposomes 0 117,7±0,2 0,075±0,011 128,1±1,06 100 0 0 0 0 
30 59,9±1,427 0,619±0,052 143,7±4,007 83,5±4,6 14,54±5,877 14,1±3,3 2,429±4,207 2,4±4,2 
 80 45,93±5,649 0,806±0,168 208,9±0,2 64,4±0,7 31,18±2,462 22,5±0,7 7,502±0,3132 13,1±0,6 
3h 30 200,2±1,2 0,587±0,002 389,7±16,49 91,9±3,3 1475±2507 5,4±1,7 2957±2564 2,7±2,3 
80 79,64±1,776 1 1275±112,1 60,5±6,9 40,82±6,545 22,7±2,5 95,16±151,8 12,9±1,8 
6h 30 165,5±0,9539 0,527±0,005 297,6±12,62 99,5±0,9 1478±2560 0,5±0,9 0 0 
80 194,8±14,74 1 2763±441,5 71,6±1,8 37,69±3,941 15,4±1,4 7,666±0,284 9,4±0,1 
24h  30 201,8±0,9018 0,537±0,005 404,2±47,43 96,3±5,2 1532±2609 3,2±4,3 1528±2647 0,5±0,9 
80 381,7±18,8 1 4060±299 66,7±11,1 33,41±3,721 14,3±3,4 7,374±0,1865 9,8±2,2 
0h lipoplexes C.R. (+/-) 4,0 0 139,7±1,058 0,098±0,021 156,9±3,493 100 0 0 0 0 
30 109,1±1,193 0,582±0,011 211,3±7,165 87,3±1,1 28,68±6,496 6,9±0,8 8,721±0,5406 5,8±0,7 
 80 58,15±0,8356 1 286±6,793 72,4±2 34,49±4,452 17,6±1,4 7,595±0,0497 9,9±0,9 
3h 30 174,1±2,974 0,598±0,006 329,5±11,11 90,3±1,7 32,74±8,228 6,2±0,2 1558±2684 3,5±1,9 
80 88,58±0,5963 1 1255±83,97 63,7±4,8 33,61±3,222 19,2±0,7 83,35±132 10,6±0,7 
6h 30 420,4±13,88 0,654±0,029 952,9±131,3 86,4±1,8 102±2,668 9,4±1 16,16±8,044 2,6±0,4 
80 216,1±44,17 1 3013±450,7 68,3±5,2 43,79±10 15,4±3 7,837±0,5718 10,7±1,6 
24h  30 1842±32,58 0,518±0,15 2907±381,5 97,7±3,9 128,6±222,7 2,3±3,9 0 0 
80 1049±258,2 1 3437±2963 42,9±15,2 23,96±15,24 23,7±3,2 224,1±375,5 18±3,5 
 
Table 4. Size and PDI of DODAC:MO:DC-Chol (6:3:1) liposomes and DNA/DODAC:MO;DC-Chol (6:3:1) lipoplexes incubated with 30% and 80% serum at different time 
points for 24h
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Time point  % serum Mean size PDI Pop. 1 % Pop. 2 % Pop. 3 % 
0h liposomes 0 122±0,3 0,059±0,025 130,9±3,037 100 0 0 0 0 
30 66,76±2,127 0,613±0,014 153±2,326 84,3±4,7 17,36±7,83 11,1±0,9 4,715±4,096 4,6±4,1 
 80 46,86±0,4262 1 273,3±34,2 63,9±2,9 35,18±7,137 23,3±1,9 7,536±0,4288 12,1±1,7 
3h 30 102,7±0,6658 0,563±0,008 203,3±4,854 92,1±2,5 8,705±1,241 6,1±0,6 8,78±15,21 1,2±3,1 
80 99,83±4,382 1 1219±162,7 59,5±4,3 32,96±3,922 17,4±1,2 141,8±76,86 13,6±2,7 
6h 30 133,2±1,286 0,526±0,004 242,3±4,592 91,9±2,4 14,68±8,492 5,1±0,4 14,37±18,99 3±2,7 
80 166,8±1,229 1 2815±276,2 62,6±2,2 35,9±3,625 18,3±1,5 91,3±144,8 10,7±0,7 
24h  30 123,1±0,7403 0,436±0,001 187,8± 4,571 93,9±0,9 12,86±6,032 4,5±1,1 1507±2605 1,6±1,6 
80 328±32,39 1 4466±189,2 64,6±3,5 34,24±1,41 16,9±0,9 51,09±76,22 9,6±1 
0h lipoplexes C.R. (+/-) 4,0 0 145,2±1,007 0,106±0,008 164,2±2,352 100 0 0 0 0 
30 114,8±0,5292 0,581±0,004 210,2±1,443 90,3±1,4 19,75±2,117 8±0,4 3,676±3,238 1,7±1,6 
 80 99,71±1,217 0,699±0,006 312,5±1,323 75,6±0,3 41,06±4,838 16,2±0,9 7,867±0,7119 8,2±0,7 
3h 30 136±1,808 0,586±0,007 257,8±6,514 88,8±2,2 26,36±6,918 8,7±0,9 4,309±3,925 2,5±2,6 
80 108,7±1,801 1 708,6±170,1 71±3,7 46,37±2,924 18,3±1,4 7,787±0,349 7,9±0,4 
6h 30 265,2±4,59 0,624±0,018 598,3±40,26 88,6±3,4 71,14±46,77 8±5,4 5,886±5,116 2,7±2,3 
80 100,2±0,2082 1 1186±122,6 59,1±1,9 103,4±62,53 17,9±1,8 89,56±90,7 14,1±1,6 
24h  30 2110±100,1 0,601±0,05 3287±144,8 100 0 0 0 0 
80 774,7±131,4 0,91±0,091 232,4±176,4 37,7±7,7 135,2±169,9 34,2±4,7 41,81±58,45 22,2±2,1 
 
Table 5. Size and PDI of DODAC:MO:DC-Chol (5:4:1) liposomes and DNA/DODAC:MO:DC-Chol (5:4:1) lipoplexes incubated with 30% and 80% serum at different time 
points for 24h.
 
 
 
 
 _____________________________________________________________________________________________________________________ Appendix 3 
 
101 
 
Time point  % serum Mean size PDI Pop. 1 % Pop. 2 % Pop. 3 % 
0h liposomes 0 117,6±0,3606 0,065±0,007 127,3±0,3055 100 0 0 0 0 
30 52,45±0,564 0,619±0,008 136,1±7,835 77±3,1 22,88±6,863 15,6±2,7 6,684±1,502 7,4±3 
 80 44,89±0,1531 1 38,73±38,73 2,9±2,9 4,912±4,912 4,1±4,1 0,1216±0,1216 0,8±0,8 
3h 30 142,4±2,751 0,512±0,026 250,8±11,34 94,2±1,2 26,7±15,17 5,8±1,2 0 0 
80 94,16±2,129 1 1258±332 61±1,1 37,34±2,854 21,2±2,2 7,561±0,03213 11,4±0,8 
6h 30 153,3±0,9644 0,474±0,007 262,7±8,524 97±3,8 1478±2539 2±2,1 2,311±4,003 1±1,7 
80 256,1±37,36 1 3174±397,5 70,2±3 32,4±3,205 15,2±1,8 7,173±0,2526 8,5±0,3 
24h  30 204,3±7,758 0,483±0,014 437,4±214,7 93,8±6,8 1594±2720 4±3,5 1517±2628 2,2±3,9 
80 450,2±91,41 1 3214±1133 60,9±24 1660±2812 17,8±11,9 13,54±9,961 11±3,7 
0h lipoplexes C.R. (+/-) 4,0 0 195,6±0,6028 0,261±0,011 260,9±30,35 98,3±2,9 1410±2442 1,7±2,9 0 0 
30 124,1±1,058 0,532±0,006 227,7±4,259 88,8±0,5 24,39±3,33 6,4±0,3 8,003±1,013 4,7±0,6 
 80 58,52±0,2629 1 292,4±8,523 72,9±0,8 33,02±1,698 17,3±0,6 7,393±0,09993 9,8±0,3 
3h 30 217,6±7,136 0,564±0,044 418,9±70,19 89,9±8,7 24,08±21,07 4,5±3,9 3069±2664 2,9±2,5 
80 73,81±3,833 1 762,2±83,78 64,7±1,4 37,23±7,47 21,1±2,5 43,04±61,19 10,5±1,4 
6h 30 152,5±15,47 0,722±0,017 356,6±450,9 84,9±6,6 31,38±2159 9,3±10,4 7,877±2924 5,9±4,6 
80 59,31±33,06 1 509,1±381,3 63,8±2,1 37,45±5,556 23,9±4,1 7,369±34,05 12,3±1 
24h  30 1790±151 0,789±0,081 3496±1197 75,9±14,6 1640±3136 15,1±8,8 11,93±4,888 4,8±3,4 
80 650,7±24,72 1 3319±503,8 43,4±11,1 58,36±5,801 23,1±4,6 278±1,02 16,7±2,3 
 
Table 6. Size and PDI of DODAC:MO:DC-Chol (4:1:1) liposomes and DNA/DODAC:MO:DC-Chol (4:1:1) lipoplexes incubated with 30% and 80% serum at different time 
points for 24h. 
  
 
 
